{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":219,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":219,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"2d921af8bae2","filters":{"venue":"JAMA Oncology"}},"results":[{"id":"W2560322684","doi":"10.1001/jamaoncol.2016.5688","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6310,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Ottawa Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Audrey and Theodor Geisel School of Medicine at Dartmouth; Norris Cotton Cancer Center; University of California, Irvine; Tehran University of Medical Sciences and Health Services; National Institutes of Health; Western Sydney University; Mekelle University; Universität Ulm; Addis Ababa University; Northumbria University; University of Gondar; National Research University Higher School of Economics; Seoul National University; Universidade do Porto; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; University of Haifa; Jimma University; Haramaya University; Universitetet i Bergen; Samfundet Folkhälsan; Shiraz University of Medical Sciences; University Of Nigeria Nsukka; Inyuvesi Yakwazulu-Natali; Massachusetts General Hospital; Universidade Federal de Minas Gerais; Wuhan University; National Center for Chronic Disease Prevention and Health Promotion; Jordan University of Science and Technology; Ahmadu Bello University; Fudan University; Universität Bielefeld; Kosin University; Umweltbundesamt; Newcastle University; United Nations Population Fund; Karolinska Institutet; Yonsei University; Pacific Institute for Research and Evaluation; Birzeit University; Trường Đại học Duy Tân; Iran University of Medical Sciences; Curtin University of Technology; Dartmouth College; Centers for Disease Control and Prevention; National Institute on Minority Health and Health Disparities; Jackson State University; Johns Hopkins University; Alborz University of Medical Sciences; National Institute for Health and Care Research; World Health Organization; Shiraz University","keywords":"Medicine; Years of potential life lost; Demography; Cancer; Life expectancy; Population; Cancer registry; Incidence (geometry); Lung cancer; Mortality rate; Gerontology; Environmental health; Surgery; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1130578404226411,"gpt":0.4077724964717964,"spread":0.2947146560491554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006148677,0.0002048932,0.0006522234,0.00005388084,0.00004848005,0.00002157646,0.0001735943,0.0002488752,0.0001504401],"category_scores_gemma":[0.0009174267,0.0001638766,0.00008025169,0.0003357376,0.0009850713,0.0002322253,0.0001875825,0.0001317676,0.000005259151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009233357,"about_ca_system_score_gemma":0.001166584,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009832742,"about_ca_topic_score_gemma":0.01719573,"domain_scores_codex":[0.997791,0.0001061208,0.0004820429,0.0006145502,0.000612065,0.0003942394],"domain_scores_gemma":[0.9980295,0.0005139863,0.0002236723,0.000289987,0.0004225204,0.0005202984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002426001,0.0001734452,0.9556195,0.0001263784,0.0001982391,0.00001907251,0.0002491362,0.00003789976,0.0001758148,0.0005469729,0.02024838,0.0201792],"study_design_scores_gemma":[0.003669052,0.001355661,0.9750178,0.0003436214,0.000175845,0.00004111292,0.0003145471,0.00006088582,0.00001047379,0.0007247279,0.0180769,0.0002093457],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782827,0.001404707,0.00009496752,0.0185345,0.0001674325,0.0009136659,0.0004070755,0.00002808244,0.0001668343],"genre_scores_gemma":[0.9929683,0.0005280027,0.001062868,0.004569413,0.0005190069,0.0002471193,0.00001655396,0.00002105063,0.00006764969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01996985,"threshold_uncertainty_score":0.9967608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2148287035","doi":"10.1001/jamaoncol.2015.0735","title":"The Global Burden of Cancer 2013","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2758,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; University of British Columbia; University of Toronto; Health Canada; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Institute of Environmental Health Sciences; Barts and The London School of Medicine and Dentistry; Wageningen University and Research; Institute of Infection and Immunity; Allergan; Mekelle University; Addis Ababa University; Università di Bologna; National Center of Neurology and Psychiatry; Universitetet i Bergen; Sahlgrenska Akademin; University of Hong Kong; Northwestern University; Universiti Tunku Abdul Rahman; Göteborgs Universitet; Kyung Hee University; National Research University Higher School of Economics; University of Queensland; Public Health Foundation of India; National Heart, Lung, and Blood Institute; Tehran University of Medical Sciences and Health Services; Australian National University; Genentech; University of Oxford; James Cook University; Wellcome Trust; University College London; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; National Institute for Health and Care Research; University of the Philippines; Institute for Health Metrics and Evaluation; Northumbria University; Faculty of Medicine and Health, University of Sydney; Philipps-Universität Marburg; Health Canada; Harvard University; Jackson State University; Karolinska Institutet; Bill and Melinda Gates Foundation; Rijksuniversiteit Groningen; Faculty of Medicine, University of British Columbia; National Institutes of Health; Regeneron Pharmaceuticals; Arak University of Medical Sciences; U.S. Department of Veterans Affairs","keywords":"Medicine; Cancer; MEDLINE; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1098126129917161,"gpt":0.4293837995996755,"spread":0.3195711866079594,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003300484,0.00006122516,0.0001980669,0.00001142601,0.00003609755,0.000007348181,0.000130391,0.0001119679,0.00007075747],"category_scores_gemma":[0.0002230038,0.0000382262,0.00004906554,0.0001366208,0.0001367836,0.00004439065,0.00005773341,0.0001153457,0.00004962503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004452698,"about_ca_system_score_gemma":0.0007403431,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01174475,"about_ca_topic_score_gemma":0.002635943,"domain_scores_codex":[0.9992512,0.00004648875,0.0001801988,0.0001062817,0.000218996,0.0001968737],"domain_scores_gemma":[0.9992539,0.00006513835,0.00009217481,0.0001770784,0.0002732516,0.0001385163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001513721,0.0000453853,0.131755,0.00001859874,0.0001298244,0.0001172469,0.0006839088,0.0002299126,0.0002581699,0.005079848,0.5045632,0.3556052],"study_design_scores_gemma":[0.001515143,0.0007499918,0.02375257,0.00003647163,0.00006425189,0.00008478443,0.001388444,0.0002819436,0.0001423045,0.001293453,0.9706419,0.00004881404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7735809,0.01096965,0.00005377009,0.08266068,0.000953929,0.0002522748,0.00001573592,0.00003297266,0.1314801],"genre_scores_gemma":[0.9954349,0.0004337569,0.0004721032,0.001932069,0.0006996873,0.0000245569,0.000002452496,0.000004506391,0.0009959908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4660786,"threshold_uncertainty_score":0.9948362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3211488171","doi":"10.1001/jamaoncol.2019.2996","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2665,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of Alberta; University of British Columbia; University of Toronto; Public Health Agency of Canada; Ottawa Hospital; University of Manitoba; Impact; McGill University; University of Calgary","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Invasive Fungi Research Center, Mazandaran University of Medical Sciences; Department of Medicine, Ottawa Hospital; Center for International Health; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; College of Medicine and Health Sciences, United Arab Emirates University; Gastrointestinal and Liver Diseases Research Center; Drug Applied Research Center, Tabriz University of Medical Sciences; Medical Research Council; Đại học Quốc gia Hà Nội; School of Public Health and Family Medicine, University of Cape Town; Comprehensive Cancer Center, University of Alabama at Birmingham; Injury Prevention Research Center; Wolkite University; Directorate for Biological Sciences; Debre Markos University; Damietta University; Universitair Ziekenhuis Antwerpen; Moscow Institute of Physics and Technology; Imam Abdulrahman Bin Faisal University; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Menzies Institute for Medical Research; Kurdistan University Of Medical Sciences; Lorestan University of Medical Sciences; Kwame Nkrumah University of Science and Technology; Universitas Hasanuddin; Savitribai Phule Pune University; McGill University; Alexandria University; Mansoura University; University of Peradeniya; Xiamen University; Universitas Airlangga; Universidad Autónoma de Sinaloa; Shahid Beheshti University of Medical Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Western Sydney University; Tartu Ülikool; College of Science and Engineering, University of Minnesota; Shiraz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Università degli Studi di Milano; Pomorski Uniwersytet Medyczny W Szczecinie; Qatar Foundation; Universidade Federal de Minas Gerais; University of Hail; Universidade do Porto; Virginia Commonwealth University; Università di Bologna; Baqiyatallah University of Medical Sciences; Shahrekord University of Medical Sciences; Chungnam National University Hospital; Universidad Nacional Autónoma de México; University of New South Wales; Kermanshah University of Medical Sciences; Birjand University of Medical Sciences; University of South Carolina; Pacific Institute for Research and Evaluation; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; University of Gondar; United Arab Emirates University; Instituto De Saúde Pública, Universidade do Porto; Ahvaz Jundishapur University of Medical Sciences; Mazandaran University of Medical Sciences; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; National Center of Neurology and Psychiatry; Mashhad University of Medical Sciences; Taipei Medical University; Tanta University; World Health Organization; Urmia University; Babol Noshirvani University of Technology; Hamadan University of Medical Sciences; Institute for Research in Fundamental Sciences; Inyuvesi Yakwazulu-Natali; Semmelweis Egyetem; University College London; Universiti Kebangsaan Malaysia; Hawassa University; Kuwait University; Tampereen Yliopisto; Tabriz University of Medical Sciences; Seoul National University Hospital; Tsinghua University; University of Cape Town; Khalifa University of Science, Technology and Research; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Frankfurt University of Applied Sciences; Kashan University of Medical Sciences; Karolinska Institutet; Kerman University of Medical Sciences; Public Health Agency of Canada; Madda Walabu University; Universidade Federal de Juiz de Fora; Institució Catalana de Recerca i Estudis Avançats; Rafsanjan University of Medical Sciences; United Nations Population Fund; Bushehr University of Medical Sciences; Kyung Hee University; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Sun Yat-sen University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Adigrat University; Morgan State University; Universitätsklinikum Heidelberg; Ottawa Hospital Research Institute; King Saud University; Ain Shams University; Cochrane South Africa; University of Toronto; Imperial College London; Public Health England; Queensland University of Technology; Cairo University; Laboratório Associado para a Química Verde; University of Health Sciences Lahore; Oklahoma State University; Flinders University; Monash University; Wuhan University; University of Washington; South African Medical Research Council; Universitas Negeri Semarang; Sydney Medical School; Newcastle University; Universitat de València; Helsingin Yliopisto; Delhi Technological University; Uniwersytet Jagielloński Collegium Medicum; Shiraz University; King's College London; McMaster University; University of Leicester; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Krishna Institute Of Medical Sciences Deemed To Be University; Universität Ulm; University of Embu; Health Services Management Research Center; Dilla University; Maragheh University of Medical Sciences; Mekelle University; National Institutes of Health; Banaras Hindu University; Wollega University; University of Tabriz; Ahmadu Bello University; Brigham and Women's Hospital; Arak University of Medical Sciences; Rede de Química e Tecnologia; Radboud Universiteit; Aksum University; Islamic Azad University; West Virginia University; University of Health and Allied Sciences; A.T. Still University; Christian Medical College, Vellore; Curtin University of Technology; Universidade Federal de Santa Catarina; Amirkabir University of Technology; Applied Molecular Biosciences Unit; Iran University of Medical Sciences; Ekiti State University; Bahir Dar University; National Center for Child Health and Development; Sheffield Hallam University; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; Seattle Children's Research Institute; Deakin University; Public Health Agency; Eli Lilly and Company; Syddansk Universitet; Jimma University; Harvard University; Postgraduate Institute of Medical Education and Research, Chandigarh; Sveučilište u Zagrebu; Seoul National University; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Anschutz Medical Campus; University of Jiroft; Durban University of Technology; University of Texas at Austin; Bournemouth University; Trường Đại học Nguyễn Tất Thành; Chungnam National University; Addis Ababa University; Ball State University; Samara University; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Oklahoma; Wellcome Trust; Johns Hopkins University; Westfälische Wilhelms-Universität Münster; St. Jude Children's Research Hospital; Trường Đại học Duy Tân; Universidade de Brasília; Case Western Reserve University; Hamad Medical Corporation; Birmingham City University; School of Medicine, Boston University; Jackson State University; University of Tasmania; Alborz University of Medical Sciences; Northwestern University; University of West Florida; Isfahan University of Medical Sciences; Instituto de Salud Carlos III; San Diego State University","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Years of potential life lost; Demography; Gerontology; Life expectancy; Population; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1092243570466877,"gpt":0.4019400534510322,"spread":0.2927156964043445,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000581305,0.0002070847,0.0007179337,0.0000542792,0.00004688689,0.00002996488,0.0001899591,0.0002614273,0.0001497736],"category_scores_gemma":[0.0005438041,0.0001982124,0.00008673852,0.0003397031,0.000674572,0.0002241291,0.0001978196,0.0002018655,0.000009029368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007440561,"about_ca_system_score_gemma":0.001133613,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01329413,"about_ca_topic_score_gemma":0.01436606,"domain_scores_codex":[0.9978005,0.00009345339,0.0004642024,0.0006406009,0.0006169617,0.0003842711],"domain_scores_gemma":[0.9982333,0.0003868711,0.0002401297,0.0003339292,0.0003646903,0.0004410808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00225498,0.0001737981,0.9777948,0.0002281956,0.000204458,0.00001648168,0.0003610687,0.0002533791,0.00009183074,0.0005188067,0.01154918,0.006553009],"study_design_scores_gemma":[0.00326434,0.00147805,0.9799229,0.0002659407,0.0001743242,0.00004360356,0.0005574602,0.0002806768,0.000006244771,0.0004076788,0.0133825,0.000216291],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896592,0.001371737,0.00002396955,0.006668442,0.0002248951,0.001279386,0.0002978197,0.00002492522,0.0004495758],"genre_scores_gemma":[0.992865,0.0003795654,0.0009757796,0.005038355,0.0004134067,0.0001917102,0.0000353889,0.00002039314,0.00008044013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006336718,"threshold_uncertainty_score":0.9932764,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761031851","doi":"10.1001/jamaoncol.2017.3055","title":"The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2020,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Johns Hopkins Bloomberg School of Public Health; Rede de Química e Tecnologia; Western Sydney University; Ingham Institute for Applied Medical Research; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Universität Ulm; Laboratório Associado para a Química Verde; Golestan University of Medical Sciences; National Research University Higher School of Economics; Texas Children's Hospital; Universitetet i Oslo; Universitetet i Bergen; Jimma University; Haramaya University; Seoul National University; Alborz University of Medical Sciences; Mekelle University; Queensland University of Technology; Universität Bielefeld; Public Health Foundation of India; Karolinska Institutet; Yonsei University; All-India Institute of Medical Sciences; Iran University of Medical Sciences; Wuhan University; Jordan University of Science and Technology; Johns Hopkins University; University of Washington; Imperial College London; Inyuvesi Yakwazulu-Natali; Fogarty International Center; Universidade do Porto; Uniwersytet Jagielloński Collegium Medicum; Case Western Reserve University; Tehran University of Medical Sciences and Health Services; Norwegian Institute of Public Health; Centers for Disease Control and Prevention; Jackson State University; Universitetet i Tromsø; Universität Basel; College of Medicine, Seoul National University; Sabin Vaccine Institute","keywords":"Medicine; Years of potential life lost; Life expectancy; Liver cancer; Cancer; Incidence (geometry); Mortality rate; Demography; Disease burden; Standardized mortality ratio; Population; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1713678529679771,"gpt":0.4053436995605343,"spread":0.2339758465925572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001319195,0.00007259749,0.0001653432,0.000009935497,0.0003492121,0.00002907409,0.00009817317,0.0000698916,0.00003278055],"category_scores_gemma":[0.0001510629,0.00003751631,0.00003031541,0.00001491233,0.0003559302,0.0000444108,0.0002164494,0.00005032092,0.000006854925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003557694,"about_ca_system_score_gemma":0.0002423433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006202067,"about_ca_topic_score_gemma":0.001527203,"domain_scores_codex":[0.9994484,0.00004281537,0.0001018221,0.0001599341,0.0001451676,0.0001019053],"domain_scores_gemma":[0.9989507,0.0005813185,0.0001066098,0.0001887919,0.0001086291,0.00006398822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001152896,0.0002207587,0.4617045,0.00004446945,0.0009075732,0.00006846393,0.001410197,0.00001987674,0.0003612829,0.003790879,0.3557807,0.1745384],"study_design_scores_gemma":[0.00111142,0.0001668706,0.8841118,0.00003949156,0.0001187821,0.00001188725,0.0002517783,0.00002339251,0.00002112957,0.00118206,0.1129245,0.00003690811],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8629529,0.01143579,0.000001691022,0.1228009,0.00009280803,0.0002557736,0.0001883157,0.000005313106,0.002266513],"genre_scores_gemma":[0.9895787,0.006829811,0.0001904622,0.002689961,0.0001975346,0.00009083519,0.00002423583,0.000004071182,0.0003943696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4224073,"threshold_uncertainty_score":0.9375712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200584507","doi":"10.1001/jamaoncol.2021.6987","title":"Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2009,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; University of Calgary; University of Alberta; Alberta Health Services; McMaster University; Ottawa Hospital; Research Canada; University of British Columbia; University of Waterloo; University of Toronto","funders":"European and Developing Countries Clinical Trials Partnership; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Division of Human Resource Development; Division of Mathematical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Erasmus Universitair Medisch Centrum Rotterdam; Amity Institute of Biotechnology, Amity University; Department of Medicine, University of Toronto; Gastrointestinal and Liver Diseases Research Center; Instituto de Salud Carlos III; Sydney Medical School; Medical Research Council; School of Public Health and Family Medicine, University of Cape Town; Lerner Research Institute, Cleveland Clinic; School of Medicine, University of Alabama at Birmingham; University of Texas Health Science Center at San Antonio; University of Oklahoma Health Sciences Center; University of Veterinary and Animal Sciences; Liverpool University Hospitals NHS Foundation Trust; George Institute for Global Health; King Faisal University; Université de Versailles Saint-Quentin-en-Yvelines; Ajman University; Laboratório Associado para a Química Verde; Cancer Research Center, Tehran University of Medical Sciences; Universidad Autónoma de Sinaloa; Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Imam Abdulrahman Bin Faisal University; Centro de Desarrollo Urbano Sustentable; Alborz University of Medical Sciences; Alzahra University; Peking Union Medical College; University Of Nigeria Nsukka; Kurdistan University Of Medical Sciences; Walailak University; Novo Nordisk Fonden; National Center of Neurology and Psychiatry; Menofia University; Mekelle University; Universitas Airlangga; Tartu Ülikool; Universidad de Chile; University of Sulaimani; Universidade Federal de Minas Gerais; Universidad Nacional Autónoma de México; National Research University Higher School of Economics; Eastern Virginia Medical School; Amirkabir University of Technology; Universidade Federal de Santa Catarina; Ajou University; Technische Universität Berlin; Trakya Üniversitesi; Universidade do Porto; University of Tsukuba; University of Dhaka; Oulun Yliopisto; Biotechnology Research Center, Tabriz University of Medical Sciences; Hokkaido University; Università di Bologna; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Shahid Beheshti University of Medical Sciences; Universitat de Barcelona; Göteborgs Universitet; Shahrekord University of Medical Sciences; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Universitetet i Oslo; Rajshahi University; Autoritatea Natională pentru Cercetare Stiintifică; Kermanshah University of Medical Sciences; Faculdade de Medicina do ABC; Pacific Institute for Research and Evaluation; Gazi Üniversitesi; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; Hamadan University of Medical Sciences; Moscow Institute of Physics and Technology; Emory University; Università di Catania; Zanjan University of Medical Sciences; United Arab Emirates University; University of Gondar; Harokopio University; University of Waterloo; Tabriz University of Medical Sciences; King Abdulaziz University; European Regional Development Fund; Karolinska Institutet; Federation University Australia; Bill and Melinda Gates Foundation; Institució Catalana de Recerca i Estudis Avançats; University of Alabama at Birmingham; Imperial College London; University of Toronto; Universitat de València; Inyuvesi Yakwazulu-Natali; Delhi Technological University; Cambridge University Hospitals; Universidad Nacional de Colombia; Gachon University; Seoul National University; University of Jordan; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Instituto Politécnico do Porto; University of Pennsylvania; National Taiwan Normal University; Cairo University; Université de Lausanne; Ottawa Hospital Research Institute; King Saud University; College of Science and Engineering, University of Minnesota; Maurice Wilkins Centre for Molecular Biodiscovery; Shiraz University of Medical Sciences; Ain Shams University; Universiti Sains Malaysia; Curtin University of Technology; Nankai University; Debre Tabor University; Universiteit Utrecht; Flinders University; Wuhan University; Alberta Health Services; University of Zanjan; University of Washington; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Amity University; Queensland University of Technology; Middlesex University; London South Bank University; Westfälische Wilhelms-Universität Münster; Indian Council of Medical Research; Uniwersytet Jagielloński Collegium Medicum; American Lebanese Syrian Associated Charities; Semmelweis Egyetem; University College London; Shiraz University; King's College London; University of Queensland; National Institute for Health and Care Research; Macquarie University; Katolicki Uniwersytet Lubelski Jana Pawla II; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Università degli Studi di Napoli Federico II; World Health Organization; Ekiti State University; University of Alberta; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Cambridge; Kasturba Medical College, Manipal; Maragheh University of Medical Sciences; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; University of Arkansas for Medical Sciences; South Eastern Sydney Local Health District; Mongolian National University of Medical Sciences; South African Medical Research Council; Mashhad University of Medical Sciences; Alexander von Humboldt-Stiftung; University of Southern California; Tribhuvan University; National Institutes of Health; Banaras Hindu University; National University of Singapore; Trường Đại học Nguyễn Tất Thành; University of Tabriz; Baki Dövlət Universiteti; European Commission; Ahmadu Bello University; James Cook University; Nord universitet; Public Health Foundation of India; Australian Catholic University; University of Cape Town; Khalifa University of Science, Technology and Research; University of Ottawa; National Institute for Medical Research Development; University of Alabama; National Authority for Scientific Research and Innovation; Barts Charity; Washington University in St. Louis; Monash University; University of Texas Health Science Center at Houston; China Medical University; Anglia Ruskin University; Jackson State University; Universidade de São Paulo; Universitatea din București; Universitas Ahmad Dahlan; Islamic Azad University; Technische Universität München; University of Colombo; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; King Abdullah University of Science and Technology; Sanofi; University of Oxford; McMaster University; Deakin University; Universidade de Lisboa; Jazan University; University of Baghdad; University of Glasgow; Umeå Universitet; Moffitt Cancer Center; Taipei Medical University; Cleveland Clinic; London School of Hygiene and Tropical Medicine; Sveučilište u Zagrebu; Centre Hospitalier Universitaire Vaudois; Johns Hopkins University; Ohio State University; Alexandria University; Rush University; Bournemouth University; Case Western Reserve University; University of Central Florida; Wellcome Trust; Pomorski Uniwersytet Medyczny W Szczecinie; Università degli Studi di Milano; Universiti Brunei Darussalam; Coventry University; Bahir Dar University; National Center for Child Health and Development; Salahaddin University-Erbil; Durban University of Technology; Krishna Institute Of Medical Sciences Deemed To Be University; Fundação para a Ciência e a Tecnologia; Universidad de Antioquia; Xiamen University; Children's Hospital of Philadelphia; Wayne State University; Jimma University; Harvard University; Boston College; Iran University of Medical Sciences; Tulane University; Western Sydney University; Brown University; United Nations Population Fund; University of Oklahoma; Ochsner Health; Kerman University of Medical Sciences; Trường Đại học Duy Tân; Isfahan University of Medical Sciences","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Gerontology; Demography; Years of potential life lost; Life expectancy; Internal medicine; Population; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1569892802779347,"gpt":0.4699616461180795,"spread":0.3129723658401448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008060496,0.0005394698,0.004353609,0.0001594243,0.00004805156,0.00003913654,0.000356646,0.00116243,0.0006544982],"category_scores_gemma":[0.002467851,0.0004826266,0.0004586504,0.0006482601,0.0006702932,0.0001148073,0.0004225335,0.001002429,0.00002699006],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001816405,"about_ca_system_score_gemma":0.009377749,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06539118,"about_ca_topic_score_gemma":0.0513889,"domain_scores_codex":[0.9956806,0.0005132846,0.001329801,0.00119816,0.0005647984,0.0007133396],"domain_scores_gemma":[0.993995,0.002646579,0.0007101131,0.001089044,0.000352041,0.001207302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000775262,0.0006486831,0.1080757,0.01818043,0.001201628,0.0001155462,0.001072652,0.000009229855,0.000003587446,0.00003056342,0.01950837,0.8503783],"study_design_scores_gemma":[0.001858146,0.001168508,0.4241681,0.007423642,0.002121061,0.00001398264,0.0001593004,0.000007834905,5.925731e-7,0.00002554702,0.5626661,0.0003871761],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2939914,0.6943222,0.00001227325,0.004980087,0.0009283509,0.003580222,0.002115312,0.00003962476,0.00003055299],"genre_scores_gemma":[0.01442038,0.976254,0.0004975055,0.004985431,0.002024551,0.0008872767,0.0005104981,0.0001451228,0.0002751634],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8499911,"threshold_uncertainty_score":0.9997625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793364080","doi":"10.1001/jamaoncol.2018.0013","title":"Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1812,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Genentech; Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Sirtex Medical; Five Prime Therapeutics; Ipsen; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; Yakult Honsha; Sanofi; Kyowa Hakko Kirin; MacroGenics; Arog Pharmaceuticals; Pfizer; Incyte; Halozyme; Amgen; Celgene; Bristol-Myers Squibb; AstraZeneca; Chugai Pharmaceutical; Agios Pharmaceuticals","keywords":"Medicine; Pembrolizumab; Internal medicine; Cancer; Cohort; Response Evaluation Criteria in Solid Tumors; Progressive disease; Clinical endpoint; Gastroenterology; Surgery; Disease; Immunotherapy; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.008114240074526269,"gpt":0.2647737009068763,"spread":0.25665946083235,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001074389,0.0003214169,0.0009671493,0.0005404492,0.00003423295,0.00001142589,0.00007450511,0.0004273516,0.0001244219],"category_scores_gemma":[0.00002723762,0.0002460001,0.00005543974,0.0003591198,0.0001983578,0.00008315715,0.00004875088,0.0006185137,0.000001295737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004770042,"about_ca_system_score_gemma":0.0001499189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002369569,"about_ca_topic_score_gemma":0.0001350371,"domain_scores_codex":[0.9983326,0.0001034384,0.0004420248,0.000487172,0.0002432171,0.0003915595],"domain_scores_gemma":[0.9990556,0.0001202627,0.0003922422,0.0002431882,0.0001194686,0.00006930292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01879761,0.0001968669,0.6120902,0.0003353751,0.0002988361,0.0001396205,0.0001755736,0.000008329628,0.000004728441,0.000001214499,0.08128508,0.2866665],"study_design_scores_gemma":[0.03758607,0.005430121,0.7738354,0.0002103228,0.000341096,0.00001533329,0.000009313161,0.00001665935,0.000003931162,0.000001984346,0.1824224,0.0001273641],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9472523,0.0007408746,0.0000519731,0.04891761,0.0002649847,0.001945365,0.00003166178,0.00003988155,0.0007553876],"genre_scores_gemma":[0.6117266,0.009715768,0.003272549,0.3560086,0.005303301,0.0005347437,0.00172416,0.0003761218,0.01133819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3355256,"threshold_uncertainty_score":0.9999992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991564522","doi":"10.1001/jamaoncol.2018.2706","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016","year":2018,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1542,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Manitoba","funders":"Medical Research Council; College of Medicine, Seoul National University; University of California, Irvine; Laboratório Associado para a Química Verde; Western Sydney University; Alborz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; University of Peradeniya; Helsingin Yliopisto; National Research University Higher School of Economics; Christian Medical College, Vellore; Tampereen Yliopisto; University of Haifa; Universitair Medisch Centrum Groningen; Haramaya University; Inyuvesi Yakwazulu-Natali; University of Gondar; Universidade Federal de Minas Gerais; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Mazandaran University of Medical Sciences; Samara University; United Nations Population Fund; Karolinska Institutet; Universidade do Porto; Seoul National University; Rijksuniversiteit Groningen; National Institute for Health and Care Research; Jordan University of Science and Technology; University of Oxford; Samfundet Folkhälsan; Maragheh University of Medical Sciences; Fudan University; Ahmadu Bello University; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Trường Đại học Duy Tân; Iran University of Medical Sciences; Rede de Química e Tecnologia; University of West Florida; National Cancer Institute; University College London; Mekelle University; Arabian Gulf University; Case Western Reserve University; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; Imperial College London; Johns Hopkins University; Curtin University of Technology; University of Washington; Aarhus Universitet; United Arab Emirates University; Jackson State University; Korea University; South African Medical Research Council; King's College London; Public Health Foundation of India; Universität Bielefeld; Kosin University; Ball State University; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Years of potential life lost; Cancer; Population; Disease burden; Global health; Demography; Epidemiology; Incidence (geometry); Environmental health; Gerontology; Public health; Life expectancy; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1869459352406655,"gpt":0.4487672438435223,"spread":0.2618213086028568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009894061,0.0004803394,0.002446335,0.0001120772,0.00007310073,0.00004522232,0.0003543063,0.0007286083,0.0001488187],"category_scores_gemma":[0.001131472,0.0004174639,0.0002876584,0.0006578623,0.001567178,0.0001960617,0.0003700881,0.000387487,0.00001160063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001732759,"about_ca_system_score_gemma":0.004235676,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01041742,"about_ca_topic_score_gemma":0.0131011,"domain_scores_codex":[0.996194,0.0002591897,0.001053787,0.001103799,0.0008319871,0.000557204],"domain_scores_gemma":[0.9967417,0.000789488,0.0006834912,0.0005109907,0.0005835298,0.0006907855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002569275,0.0005809585,0.250778,0.01455037,0.001959316,0.00008118415,0.0004451314,0.00002413443,0.000001270837,0.0005769697,0.09957705,0.6288564],"study_design_scores_gemma":[0.00188162,0.001662173,0.2824713,0.007559767,0.001502637,0.0001108376,0.0001456278,0.00002044297,1.335243e-7,0.0002158714,0.7039922,0.0004373878],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.234617,0.7586049,0.00002376514,0.001951592,0.0003809922,0.002860006,0.001270383,0.00003799981,0.000253401],"genre_scores_gemma":[0.02886702,0.9628008,0.00138189,0.003429735,0.002049878,0.001080699,0.0001960033,0.00007591432,0.0001180406],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.628419,"threshold_uncertainty_score":0.9998277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.023995485520902,"gpt":0.2317533058969982,"spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001102628,0.0003067554,0.0009543969,0.0001275571,0.00004889431,0.000009243133,0.00009365212,0.0002230116,0.00005568265],"category_scores_gemma":[0.00006113968,0.0002221654,0.000063466,0.0004487536,0.0001864194,0.0001154158,0.00005623144,0.0002813768,0.000008907393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002892873,"about_ca_system_score_gemma":0.0003720966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001446771,"about_ca_topic_score_gemma":0.00005004143,"domain_scores_codex":[0.998207,0.0001603407,0.0004523515,0.0005227741,0.0002614518,0.0003960505],"domain_scores_gemma":[0.99891,0.0001331689,0.0002087807,0.0002770147,0.0001723989,0.0002986274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03483114,0.0006886204,0.9416983,0.0001980822,0.0001562057,0.0006551055,0.001329719,0.000006015737,0.0002675622,0.00001865006,0.00004138757,0.02010917],"study_design_scores_gemma":[0.09243507,0.02387923,0.8758689,0.0001929431,0.0004697821,0.00003343372,0.0001559943,0.001917701,0.002480461,0.000002343946,0.002288205,0.0002759427],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947886,0.0006169438,0.00002658973,0.001066659,0.00001525949,0.002404269,0.0000178839,0.00005506717,0.001008653],"genre_scores_gemma":[0.9980942,0.00006523076,0.001118808,0.0003095015,0.00003762009,0.00008594119,0.0001848283,0.00004931338,0.00005454699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06582944,"threshold_uncertainty_score":0.905964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2959096163","doi":"10.1001/jamaoncol.2019.1588","title":"Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Medicine; Tremelimumab; Gemcitabine; Internal medicine; Population; Combination therapy; Oncology; Surgery; Cancer; Immunotherapy; Ipilimumab; Nivolumab","retraction":null,"screen_n_in":null,"score":{"opus":0.03113434771125084,"gpt":0.3374684671745833,"spread":0.3063341194633324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004758944,0.000356475,0.001600925,0.0002350379,0.000128957,0.00002763373,0.0002029873,0.0002343746,0.001157099],"category_scores_gemma":[0.0003592836,0.0002017207,0.000105195,0.0003297795,0.0003390003,0.0001777122,0.00005990702,0.0004048344,0.0002540074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005016271,"about_ca_system_score_gemma":0.001910985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001037177,"about_ca_topic_score_gemma":0.0001990169,"domain_scores_codex":[0.9972832,0.0002254123,0.0004774306,0.000639767,0.0005701918,0.0008040169],"domain_scores_gemma":[0.9971576,0.001068914,0.0002534012,0.000599848,0.0005828161,0.0003373625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03719622,0.001284541,0.9550898,0.0004116548,0.001004683,0.000234411,0.0005609092,0.000003173404,0.00007860424,0.0002030884,0.001238028,0.002694875],"study_design_scores_gemma":[0.06121912,0.0594485,0.8641092,0.0002388933,0.002272729,0.0008651292,0.001035669,0.002014714,0.00003810411,0.00008721192,0.008291462,0.0003792788],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849966,0.00013624,0.0005196723,0.00148014,0.0001075886,0.004414446,0.00003765801,0.00007738941,0.008230265],"genre_scores_gemma":[0.9660481,0.00003045277,0.02248543,0.000959584,0.0001626792,0.0006446024,0.0001533202,0.00008552009,0.009430312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09098063,"threshold_uncertainty_score":0.999756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105956673","doi":"10.1001/jamaoncol.2014.168","title":"Hereditary Diffuse Gastric Cancer Syndrome","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":687,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Dr. H. Bliss Murphy Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Vancouver General Hospital; Occupational Cancer Research Centre; McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Germline mutation; Medicine; Breast cancer; Cancer; Penetrance; CHEK2; Proband; Genetics; Oncology; Mutation; CDH1; Genetic testing; Internal medicine; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02580639391782371,"gpt":0.2901571075128544,"spread":0.2643507135950307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002358222,0.0001552971,0.0001955289,0.00005190311,0.00004601233,0.00001765105,0.0002557706,0.0003043271,0.0001936431],"category_scores_gemma":[0.00008122986,0.0001429962,0.00006210255,0.0001284691,0.00009111117,0.000005982108,0.0001518308,0.0001415505,0.00008647221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001287705,"about_ca_system_score_gemma":0.0006145608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008479036,"about_ca_topic_score_gemma":0.00007428618,"domain_scores_codex":[0.9989148,0.00007890676,0.0002020405,0.0003268199,0.0001521467,0.0003253129],"domain_scores_gemma":[0.9993606,0.00001530543,0.00008470319,0.0002200475,0.0001354169,0.0001839552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005023176,0.0003393421,0.0232975,0.00002411723,0.0002585885,0.0004026412,0.0002693893,0.0002454922,0.08362861,0.00005687392,0.8617737,0.02920145],"study_design_scores_gemma":[0.002624668,0.0010177,0.008733695,0.00001711636,0.00004099631,0.0005722325,0.0001835445,0.00003701856,0.01716218,0.0002264454,0.9690326,0.0003518375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850428,0.003019709,0.0002168471,0.001653329,0.001435931,0.0001351643,0.00001736333,0.00003081385,0.008448091],"genre_scores_gemma":[0.9892688,0.0003114924,0.001004503,0.002007184,0.0009803525,0.0001297674,0.0001136223,0.0000300594,0.006154225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1072589,"threshold_uncertainty_score":0.5831214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016210953","doi":"10.1001/jamaoncol.2020.0237","title":"Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":628,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Internal medicine; Oncology; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Nivolumab; Ipilimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.03414082962539107,"gpt":0.3314500925352575,"spread":0.2973092629098664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001507008,0.0002631968,0.001056728,0.0001054562,0.0000345368,0.000009013141,0.00009870582,0.0001274181,0.00104185],"category_scores_gemma":[0.00001600725,0.0001658989,0.0001282979,0.000397705,0.0001272849,0.00004628982,0.0000128394,0.0001378667,0.000003076542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009495113,"about_ca_system_score_gemma":0.001269566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001452897,"about_ca_topic_score_gemma":0.007146713,"domain_scores_codex":[0.9985371,0.00007907631,0.0004939336,0.000362555,0.0002107002,0.0003166452],"domain_scores_gemma":[0.9991516,0.000127929,0.0002470523,0.0002354625,0.0001037984,0.0001341108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.5245523,0.003030714,0.1486146,0.001399837,0.001876057,0.0008613258,0.02127974,0.0002786918,0.01994678,0.000004544504,0.00300596,0.2751495],"study_design_scores_gemma":[0.3272753,0.1354826,0.05316571,0.0008410638,0.001802518,0.0001905671,0.002611539,0.01043607,0.09792966,0.00000934141,0.3693995,0.0008561562],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9744195,0.00210618,0.0004002909,0.02039682,0.000101444,0.001502251,0.00006585765,0.00003492863,0.0009727614],"genre_scores_gemma":[0.9860825,0.005238846,0.00324263,0.004136979,0.000179675,0.0002466521,0.00002140516,0.00005449259,0.0007968526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3663935,"threshold_uncertainty_score":0.9998713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2592294322","doi":"10.1001/jamaoncol.2016.5945","title":"Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":529,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; National Heart, Lung, and Blood Institute; Anschutz Medical Campus, University of Colorado; Health Research Council of New Zealand; University of Texas Health Science Center at San Antonio; University of California, San Diego; National Institutes of Health; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Vincent Fairfax Family Foundation; World Health Organization; Wellcome Trust; Cancer Research UK; Morehouse School of Medicine; Johns Hopkins University; National Jewish Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute of Neurological Disorders and Stroke; British Heart Foundation; University of Pittsburgh; University of Minnesota; Brigham and Women's Hospital; Canadian Institutes of Health Research; Cancerfonden; NHLBI Division of Intramural Research; Motor Neurone Disease Association; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Temple University; South London and Maudsley NHS Foundation Trust; Deutsche Forschungsgemeinschaft; National Cancer Institute; University of Bristol; GlaxoSmithKline; King's College London; World Cancer Research Fund; American Heart Association","keywords":"Medicine; Telomere; Cancer; Oncology; Internal medicine; Genetics; DNA; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01448770962222359,"gpt":0.3185083507505348,"spread":0.3040206411283112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001963649,0.0001206213,0.0004930815,0.00007357159,0.0002052261,0.00002670187,0.00008328213,0.0002118727,0.00003770372],"category_scores_gemma":[0.001402523,0.0001016573,0.00004143278,0.0000401061,0.0002005919,0.0001200121,0.00008337881,0.0002156602,0.000005314531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001268017,"about_ca_system_score_gemma":0.0001795421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001653431,"about_ca_topic_score_gemma":0.001056332,"domain_scores_codex":[0.9991029,0.00005614469,0.000225392,0.0002369704,0.0001601175,0.0002184729],"domain_scores_gemma":[0.9983855,0.0006301088,0.0004483892,0.0002443633,0.0001169513,0.0001746619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001198643,0.00005433791,0.8726654,0.000106127,0.0002394835,0.00001704779,0.0002205833,3.280885e-7,0.0003545087,0.00001098643,0.001268318,0.124943],"study_design_scores_gemma":[0.002332053,0.0004115118,0.9873432,0.00008387933,0.0008715189,0.000006100528,0.0001007782,0.00007372987,0.0004659336,0.00009744408,0.008114906,0.00009894622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954464,0.00129514,0.00001182475,0.001774033,0.0002032383,0.0001983763,0.0001705846,0.00001818568,0.0008821483],"genre_scores_gemma":[0.9929379,0.005736412,0.0001776559,0.0001224775,0.0004348602,0.00001645373,0.00001033547,0.00001260607,0.0005513226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1248441,"threshold_uncertainty_score":0.4145465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997720498","doi":"10.1001/jamaoncol.2019.5570","title":"Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":436,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pharmacyclics; Genentech; Merck Canada; Deutschen Konsortium für Translationale Krebsforschung; Radboud Universitair Medisch Centrum; Melanoma Institute Australia; Amgen; Radboud Universiteit; Universitat de Barcelona; Astellas Pharma; Les Laboratories Pierre Fabre; European Organisation for Research and Treatment of Cancer; SkylineDx; Sun Pharma; Peter MacCallum Cancer Centre; Syndax Pharmaceuticals; Regeneron Pharmaceuticals; Endocyte; Array BioPharma; Aix-Marseille Université; InflaRx; Pfizer; Incyte; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline; NeraCare; University of Sydney; Medizinischen Hochschule Hannover; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Clinical trial; Melanoma; Oncology; Surgery; Cancer; Immunotherapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01442860837970582,"gpt":0.2701461534137153,"spread":0.2557175450340095,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000988694,0.0002362747,0.001088928,0.000105792,0.00009885826,0.00001087672,0.0001401814,0.0003587804,0.0004197507],"category_scores_gemma":[0.001486884,0.0001679179,0.0001434409,0.0003713865,0.0001148533,0.0001436031,0.0001037082,0.0003765213,0.00002297933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006229864,"about_ca_system_score_gemma":0.0002981707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004167222,"about_ca_topic_score_gemma":0.0002569681,"domain_scores_codex":[0.997578,0.0006024794,0.0006755108,0.0003982319,0.0004016485,0.0003441372],"domain_scores_gemma":[0.9978319,0.0009342015,0.000546696,0.0002357995,0.0002083255,0.0002430905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5861143,0.0001211869,0.3975838,0.00004328692,0.001539861,0.0000364495,0.00260067,0.000003156258,0.00006455532,0.000004970158,0.001819553,0.01006817],"study_design_scores_gemma":[0.4363849,0.003145244,0.5519953,0.0001106264,0.000448348,0.000002654764,0.0003067271,0.00004619257,0.00007230412,0.00001051617,0.007286671,0.0001904689],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882669,0.00008076887,0.00006082262,0.006333456,0.0003636943,0.002285753,0.0001162783,0.00006559325,0.002426701],"genre_scores_gemma":[0.9958522,0.0001457948,0.0002542732,0.0008584603,0.0001402682,0.0001203142,0.0001996247,0.00003229064,0.002396831],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1544115,"threshold_uncertainty_score":0.6847493,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2743199111","doi":"10.1001/jamaoncol.2017.2319","title":"Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Sarcopenia; Internal medicine; Body mass index; Cancer; Colorectal cancer; Systemic inflammation; Overweight; Oncology; Inflammation; Surrogate endpoint; Prospective cohort study; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.02916991970643443,"gpt":0.3635976434972987,"spread":0.3344277237908643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005754057,0.00004773327,0.0002865955,0.00007363583,0.0000591264,0.0000116855,0.0000339064,0.000092567,0.00003541261],"category_scores_gemma":[0.0002158799,0.00004019846,0.00001030205,0.00003692409,0.00004308746,0.00008852954,0.00001677317,0.000137538,0.000003450178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003879199,"about_ca_system_score_gemma":0.0002111804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005418066,"about_ca_topic_score_gemma":0.003686657,"domain_scores_codex":[0.9993691,0.00009184447,0.0002163275,0.00009286767,0.0001144239,0.0001154188],"domain_scores_gemma":[0.9992818,0.000142664,0.0003537145,0.0000778527,0.000100029,0.00004388921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006162873,0.00004332369,0.9708337,0.0004800899,0.00003020726,0.00002532105,0.0007123105,0.000003145575,0.01149896,0.0002047566,0.0002057513,0.01534616],"study_design_scores_gemma":[0.005814784,0.0004154221,0.9897037,0.0004995582,0.0000483275,0.0000404025,0.0002750057,0.0003768368,0.001365319,0.00005977571,0.001355925,0.00004493041],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858078,0.0001050748,0.00001638698,0.01142077,0.0001472557,0.0003383208,0.000006191641,0.00000721871,0.002151018],"genre_scores_gemma":[0.9986448,0.0002526572,0.0006418735,0.0001137598,0.00009971299,0.00004513643,0.000005637881,0.000005656412,0.0001907495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01887004,"threshold_uncertainty_score":0.2057241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2937981811","doi":"10.1001/jamaoncol.2018.7147","title":"Current Landscape of Immunotherapy in Breast Cancer","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health","keywords":"Medicine; Breast cancer; Immunotherapy; Oncology; Clinical trial; Cancer; Immune checkpoint; Internal medicine; Tumor microenvironment","retraction":null,"screen_n_in":null,"score":{"opus":0.01282714036213329,"gpt":0.3246704946452061,"spread":0.3118433542830729,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002065661,0.00008563622,0.0003362198,0.0001280825,0.000007582905,0.000003030949,0.00007654126,0.0001199604,0.003127509],"category_scores_gemma":[0.00000387694,0.00006763168,0.00009071302,0.0002084115,0.00004922587,0.00004146095,0.00001537783,0.0001795084,0.00003013203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001851863,"about_ca_system_score_gemma":0.0003271179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004515188,"about_ca_topic_score_gemma":0.0001115852,"domain_scores_codex":[0.9992593,0.00004538501,0.000268013,0.0001496337,0.0001056168,0.0001720428],"domain_scores_gemma":[0.9995694,0.00005346834,0.0001057958,0.000188028,0.00005413671,0.00002922404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006561253,0.0003125321,0.4733438,0.00007298115,0.00007101614,0.000006939795,0.0003341161,0.000002690286,0.05109853,0.00004397737,0.003286717,0.4648655],"study_design_scores_gemma":[0.009262769,0.0004303076,0.7766059,0.0002042342,0.00001154214,0.00006210867,0.0001071939,0.00005738127,0.0009593173,0.00001948226,0.2122051,0.00007466418],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792,0.009159363,0.000002649145,0.006106045,0.0007126307,0.0002959214,0.00002233341,0.00001315049,0.004487924],"genre_scores_gemma":[0.9918062,0.00650137,0.00004392286,0.001198193,0.0001352815,0.00003110972,0.00000904205,0.00001294643,0.000261915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4647909,"threshold_uncertainty_score":0.9977838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770975168","doi":"10.1001/jamaoncol.2017.5029","title":"Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute","keywords":"Vemurafenib; Medicine; V600E; Langerhans cell histiocytosis; Internal medicine; Progression-free survival; Melanoma; Oncology; Adverse effect; Positron emission tomography; Dermatology; Cancer research; Radiology; Chemotherapy; Disease; Mutation; Metastatic melanoma","retraction":null,"screen_n_in":null,"score":{"opus":0.0307705264303714,"gpt":0.3246722442241393,"spread":0.2939017177937679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001024276,0.0001653706,0.0003651594,0.00004924671,0.0003126628,0.00005447945,0.0001100964,0.0001496857,0.00008421057],"category_scores_gemma":[0.0002013403,0.0001358591,0.0001036864,0.00002007951,0.0001950639,0.00009742996,0.00006457149,0.0001044044,0.00006529544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001792757,"about_ca_system_score_gemma":0.0002305938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008693938,"about_ca_topic_score_gemma":0.00007665849,"domain_scores_codex":[0.9990714,0.00002334552,0.0001872261,0.0003253462,0.0001062063,0.0002865108],"domain_scores_gemma":[0.9988885,0.0001219812,0.0001465556,0.0004631882,0.00007062799,0.0003091822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007134652,0.005110798,0.1496293,0.001097482,0.0007688157,0.002796629,0.001889915,0.000002466601,0.006887501,0.00219223,0.0808091,0.7416811],"study_design_scores_gemma":[0.01590699,0.001433643,0.07934411,0.00007240094,0.0009927317,0.00006201601,0.0001109398,0.0002392779,0.0008826839,0.0008788519,0.8998377,0.0002386954],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.948798,0.0008388961,0.000211968,0.01731509,0.0004345622,0.0009195135,0.0001681944,0.00005569261,0.03125806],"genre_scores_gemma":[0.9897346,0.000161866,0.00111845,0.002346581,0.0002430956,0.0001911964,0.00006959761,0.00003051975,0.006104101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8190286,"threshold_uncertainty_score":0.5540173,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4309183974","doi":"10.1001/jamaoncol.2022.5370","title":"Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Université de Sherbrooke","funders":"Houston Methodist Research Institute; University of California, San Diego; Saint Luke's Health System; Northwell Health; National Cancer Institute; University College London; Kaiser Permanente; Université de Sherbrooke; Moffitt Cancer Center; Houston Methodist Hospital; Montreal Neurological Institute and Hospital; University of California, Los Angeles; University of South Carolina; McGill University; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Tufts Medical Center; University of Miami; Hollings Cancer Center, Medical University of South Carolina; Brown University","keywords":"Medicine; Temozolomide; Internal medicine; Clinical endpoint; Placebo; Clinical trial; Oncology; Hazard ratio; Glioblastoma; Randomization; Chemotherapy; Surgery; Confidence interval; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.007123232567838385,"gpt":0.2384052351905859,"spread":0.2312820026227475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002448233,0.0001408388,0.0005151963,0.0001921492,0.00008009662,0.000005397383,0.00004935056,0.00007871163,0.0000770628],"category_scores_gemma":[0.000146213,0.00009884922,0.0000439606,0.0002684041,0.00003897406,0.00006334452,0.0000652802,0.0001748757,9.649016e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00050963,"about_ca_system_score_gemma":0.0001278705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001212624,"about_ca_topic_score_gemma":0.0004277727,"domain_scores_codex":[0.9985195,0.0002630764,0.000324614,0.0002657567,0.0004272575,0.000199732],"domain_scores_gemma":[0.998373,0.0004538337,0.0005736155,0.0001629143,0.0003571884,0.00007946057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002623343,0.003907113,0.9773771,0.0001032898,0.0001563232,0.0002213414,0.0005184027,0.00006044772,0.001466654,0.00002487114,0.0006008573,0.01294032],"study_design_scores_gemma":[0.01752173,0.01716665,0.9573804,0.00005655763,0.0004255623,0.00001903178,0.0003866777,0.0001931984,0.006456407,0.00001326664,0.0002837529,0.00009673466],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981126,0.00008566328,0.000005200068,0.0006672767,0.0001669812,0.000705308,0.00003749467,0.00002155398,0.0001979156],"genre_scores_gemma":[0.9993799,0.00001650372,0.0002459653,0.00007511433,0.0000182722,0.0001393938,0.0000746955,0.00001864282,0.00003147758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01999662,"threshold_uncertainty_score":0.4030955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765953690","doi":"10.1001/jamaoncol.2017.3290","title":"Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Royal Alexandra Hospital; Vancouver General Hospital; Alberta Health Services; University of British Columbia; University of Calgary","funders":"National Center for Advancing Translational Sciences; Cancer Research UK; National Cancer Institute; National Center for Research Resources; Fogarty International Center; Francis Crick Institute","keywords":"Medicine; Tumor-infiltrating lymphocytes; Serous fluid; Oncology; CD8; Internal medicine; Ovarian cancer; Survival analysis; Immunotherapy; Cancer; Immune system; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01761508240589437,"gpt":0.3084004166534542,"spread":0.2907853342475599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001542414,0.0001440513,0.0005253464,0.0001161419,0.0001320501,0.00003795333,0.0001323896,0.0002567724,0.0002110946],"category_scores_gemma":[0.0008054337,0.0001320278,0.00006783303,0.00009780839,0.0001378023,0.0001373902,0.00005221096,0.0001916708,0.000007010498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001156443,"about_ca_system_score_gemma":0.0007165413,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008452123,"about_ca_topic_score_gemma":0.001423695,"domain_scores_codex":[0.9985284,0.0003447554,0.0003979504,0.0002428365,0.0001990913,0.0002870345],"domain_scores_gemma":[0.9983897,0.0006791445,0.0004864669,0.0002879552,0.00009001316,0.00006676377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03430128,0.0003837808,0.6150511,0.0001246483,0.0004555301,0.000245286,0.00285646,0.00005789823,0.2680405,0.0000791753,0.002484518,0.07591982],"study_design_scores_gemma":[0.01748741,0.0008719851,0.9647395,0.0001505582,0.00007792734,0.00005679351,0.0002820196,0.001265748,0.005913992,0.00005129246,0.008947015,0.0001557554],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859039,0.0003187989,0.000002320296,0.01201378,0.0002475969,0.0002818069,0.00003819201,0.0000234762,0.001170174],"genre_scores_gemma":[0.9972073,0.000175233,0.0003315283,0.0007856959,0.0002515848,0.00003643701,0.00001008839,0.00001910043,0.001183035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3496884,"threshold_uncertainty_score":0.9981507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3021442601","doi":"10.1001/jamaoncol.2020.0910","title":"Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Canadian Red Cross Society; Dalhousie University; Moncton Hospital; Juravinski Cancer Centre; Ottawa Hospital; Saskatchewan Cancer Agency; St. John’s Health Sciences Centre; Université de Sherbrooke; Queen's University; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Ipsen; Eisai; Celgene; Amgen","keywords":"Medicine; Microsatellite instability; Internal medicine; Colorectal cancer; Oncology; Cetuximab; Regorafenib; Tremelimumab; Irinotecan; Cancer; Ipilimumab; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.005834023752853325,"gpt":0.273599230731202,"spread":0.2677652069783487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001359715,0.0001612409,0.000633709,0.00007342676,0.0000240979,0.000003297076,0.00004861736,0.000163041,0.0001749667],"category_scores_gemma":[0.00007670848,0.0001227227,0.00009263284,0.0003072475,0.000152711,0.00007432292,0.00003200481,0.000235032,0.000005453295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005025812,"about_ca_system_score_gemma":0.0002551678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000345431,"about_ca_topic_score_gemma":0.0002855156,"domain_scores_codex":[0.9988371,0.0001333804,0.0004006028,0.0002423867,0.0001738711,0.0002126759],"domain_scores_gemma":[0.9993144,0.00009583288,0.0002473586,0.00009943737,0.0001660501,0.00007689828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3485377,0.0006622286,0.3722331,0.0006602395,0.000245529,0.0001066233,0.004758575,0.00001698993,0.1504605,0.00000236453,0.0001746756,0.1221415],"study_design_scores_gemma":[0.05409076,0.06899311,0.5277138,0.0003072621,0.0001116313,0.000004110177,0.0004695312,0.00001724762,0.3473959,7.850723e-7,0.0007630623,0.0001328868],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954535,0.0004839702,0.000002688076,0.002117718,0.000140727,0.001206818,0.00005359966,0.00002195056,0.0005190678],"genre_scores_gemma":[0.9988055,0.00008197123,0.00006415942,0.0005893335,0.00004669161,0.0001590712,0.0002200053,0.00002124046,0.00001201308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2944469,"threshold_uncertainty_score":0.5004488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2403998898","doi":"10.1001/jamaoncol.2016.0494","title":"Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Enzalutamide; Prostate cancer; Medicine; Interquartile range; Oncology; Internal medicine; Cell-free fetal DNA; Prostate-specific antigen; Cancer; Androgen deprivation therapy; Androgen receptor; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02452938334777873,"gpt":0.3308476599576475,"spread":0.3063182766098688,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550051,0.0001159133,0.0002565492,0.0001964137,0.0000496671,0.00001799919,0.00007663265,0.000115742,0.0001020287],"category_scores_gemma":[0.00008840636,0.00007822253,0.00002318606,0.0001791594,0.0001426795,0.0001196049,0.0000520131,0.0001647524,0.00001194038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001030824,"about_ca_system_score_gemma":0.0007970233,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005483668,"about_ca_topic_score_gemma":0.03588338,"domain_scores_codex":[0.9988305,0.0001040243,0.0002962807,0.0003035322,0.0001251486,0.0003405103],"domain_scores_gemma":[0.999348,0.0001916226,0.00006382632,0.0002274858,0.00006505114,0.0001039963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006173318,0.0004461355,0.1773841,0.0001971934,0.0000406572,0.00117485,0.00353038,0.000006285965,0.7819175,0.001194623,0.005799318,0.0221357],"study_design_scores_gemma":[0.02583379,0.0008780787,0.8890166,0.0004739781,0.00003775886,0.00002257033,0.000420293,0.00002667756,0.02840983,0.003397026,0.05124104,0.000242415],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9604585,0.003353446,0.000003455905,0.02886661,0.00008820726,0.0006701549,0.00007924946,0.00001449716,0.006465864],"genre_scores_gemma":[0.986956,0.002559217,0.0004726403,0.0003500611,0.0001065338,0.0003622188,0.0000129591,0.00001591288,0.009164471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7535076,"threshold_uncertainty_score":0.9817092,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2283816551","doi":"10.1001/jamaoncol.2015.6113","title":"Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":375,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; BC Cancer Agency; McGill University; University of Calgary; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Hazard ratio; Neoadjuvant therapy; Randomized controlled trial; Cancer; Clinical trial; Lapatinib; Trastuzumab; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.03141613759811938,"gpt":0.362242651247462,"spread":0.3308265136493426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004415181,0.0004463986,0.001699132,0.000151325,0.00004339144,0.00001000593,0.0002665242,0.0006248417,0.00004373565],"category_scores_gemma":[0.00009381583,0.0002689986,0.0002540635,0.0001764391,0.0001073913,0.000004519847,0.0001704402,0.0001846417,0.00001835967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009586842,"about_ca_system_score_gemma":0.0005932845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001448927,"about_ca_topic_score_gemma":0.001143409,"domain_scores_codex":[0.9973752,0.00095538,0.0005005348,0.0005992795,0.000169324,0.0004002937],"domain_scores_gemma":[0.998336,0.0003284728,0.0006799243,0.0003675972,0.0002182005,0.00006980389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002653082,0.0002844227,0.06278145,0.0002611467,0.001118208,0.0001276324,0.0001165328,8.756306e-7,0.0002931614,0.000002818162,0.0005588829,0.9318018],"study_design_scores_gemma":[0.003331552,0.001804026,0.5790002,0.002861033,0.0002915158,0.0001662754,0.00001702071,2.59519e-8,0.00005224317,0.000003485925,0.4120407,0.0004319008],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03261869,0.9574559,0.00002560199,0.00525138,0.0002898706,0.00140876,0.002763915,0.00001553614,0.0001703764],"genre_scores_gemma":[0.006066845,0.9915193,0.0001000369,0.0006355363,0.0001892604,0.0007927859,0.0001771047,0.00005192591,0.0004672592],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9313699,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2809263049","doi":"10.1001/jamaoncol.2018.1771","title":"Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institutes of Health; Hellenic Health Foundation; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Umeå Universitet; Medical Research Council; Samfundet Folkhälsan; Graduate School of Public Health, University of Pittsburgh; Karolinska Institutet; National Cancer Institute; University of Toronto; National University of Singapore; University of Oxford; Norges Teknisk-Naturvitenskapelige Universitet; Deutsches Krebsforschungszentrum; University of Pittsburgh; Duke-NUS Medical School; Imperial College London; Universitetet i Oslo; Helsingin Yliopisto; Universiteit Utrecht; World Health Organization; Aarhus Universitet; University of Southern California","keywords":"Medicine; Body mass index; Breast cancer; Oncology; Gynecology; Cancer; Association (psychology); Internal medicine; Obstetrics; Gerontology","retraction":null,"screen_n_in":null,"score":{"opus":0.009468008879487547,"gpt":0.2933573706393742,"spread":0.2838893617598867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003046667,0.00007773485,0.000298324,0.00008133006,0.0000203978,0.000005770923,0.00003198494,0.0001513148,0.0002757304],"category_scores_gemma":[0.00003308219,0.00005984302,0.00001093084,0.0001310083,0.00009619576,0.00004894443,0.00001869276,0.0001896226,0.000002193062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00138318,"about_ca_system_score_gemma":0.0002532354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005807987,"about_ca_topic_score_gemma":0.01166566,"domain_scores_codex":[0.9992422,0.00006199031,0.0001767824,0.0001567417,0.00014448,0.0002177752],"domain_scores_gemma":[0.9994735,0.00005127679,0.00020094,0.00009599761,0.0001028232,0.00007547736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001602517,0.00009960225,0.9802364,0.00002658505,0.0001009682,0.00003059387,0.001415052,0.000002271843,0.003966154,0.0000151242,0.0007428408,0.01176187],"study_design_scores_gemma":[0.004070288,0.001716132,0.982462,0.00003884565,0.00004614252,0.00001499129,0.0002639072,0.00007736305,0.0002709405,0.00006821543,0.01090826,0.00006289387],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963911,0.00004919989,0.00001640985,0.001404039,0.0001128323,0.0002163399,0.00005324209,0.00001049355,0.00174641],"genre_scores_gemma":[0.9987009,0.0002310068,0.00005958771,0.0002453857,0.0002534667,0.00004921035,0.000004507563,0.0000103324,0.0004455711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01169898,"threshold_uncertainty_score":0.8779978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008735477","doi":"10.1001/jamaoncol.2019.6716","title":"Global Retinoblastoma Presentation and Analysis by National Income Level","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Cliniques Universitaires Saint-Luc; Emory Eye Center; NIH Clinical Center; National Cancer Institute; Faculty of Medicine and Health, University of Sydney; School of Medicine, Shanghai Jiao Tong University; College of Medicine, University of Cincinnati; Université de Paris; Servicio Andaluz de Salud; Universitas Andalas; Centre hospitalier universitaire Sainte-Justine; Masarykova Univerzita; Dali University; Universitas Airlangga; University of Cape Town; Hospital for Sick Children; Addis Ababa University; Anna University; Université Mohammed V de Rabat; Aarhus Universitet; University of Ghana; Prince of Songkla University; Jimma University; Hospital Infantil de México Federico Gómez; Università degli Studi di Padova; Universitas Udayana; Shanghai Jiao Tong University; Hacettepe Üniversitesi; Tel Aviv University; Seoul National University Hospital; Faculdade de Medicina da Universidade de São Paulo; Mahidol University; Hebrew University of Jerusalem; Universitätsklinikum Hamburg-Eppendorf; Universiteit Stellenbosch; Universidade de São Paulo; Chulalongkorn University; Centre Hospitalier Universitaire Vaudois; Northwestern University; Seoul National University; Helsingin Yliopisto; Semmelweis Egyetem; University of Cincinnati; Amsterdam University Medical Centers; Universitätsklinikum Essen; Birmingham Women's and Children's NHS Foundation Trust; Leonard M. Miller School of Medicine; Indus Hospital; University of Southern California; Children's Hospital Colorado; Cleveland Clinic; Hadassah Medical Organization; Guangxi Medical University; Iran University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Universidade de Coimbra; University of Miami; University of South Carolina; University of Louisville; Johns Hopkins University; Feinberg School of Medicine; Ankara Universitesi; Ege Üniversitesi; Università degli Studi di Siena; Chang Gung Medical Foundation; Children's Hospital Los Angeles; St. Jude Children's Research Hospital; Aarhus Universitetshospital; Universidad de Chile; Emory University; Inyuvesi Yakwazulu-Natali; University of Otago; Consejo Nacional de Investigaciones Científicas y Técnicas; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Retinoblastoma; Interquartile range; Pediatrics; Cohort; Strabismus; Referral; Surgery; Internal medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03398779889015197,"gpt":0.3545768754051521,"spread":0.3205890765150001,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001041071,0.00008734773,0.0002847107,0.00005339739,0.00005330804,0.000008448712,0.00003970614,0.0002037726,0.0001811411],"category_scores_gemma":[0.0002299396,0.00007839328,0.00007001771,0.0004204139,0.00009210328,0.00006745334,0.00004535287,0.0001004178,0.0000520972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002202885,"about_ca_system_score_gemma":0.0001577855,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003803365,"about_ca_topic_score_gemma":0.00005884029,"domain_scores_codex":[0.9991906,0.0001007663,0.0001698648,0.0002370632,0.0001747169,0.0001270333],"domain_scores_gemma":[0.9995061,0.00009725537,0.0000775978,0.0000615046,0.0001043983,0.0001531802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006209526,0.0002270016,0.9686761,0.00001779679,0.001327474,0.0001544569,0.0001741503,0.00001067374,0.0002845605,0.0005871649,0.01609944,0.01182017],"study_design_scores_gemma":[0.003920694,0.001287445,0.9656944,0.000003114817,0.0009362125,0.00007865395,0.00005902077,0.001572679,0.000136286,0.0003164206,0.02592483,0.0000702438],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9485743,0.0002027759,0.000998358,0.03467334,0.00005995864,0.000215355,0.0001566223,0.00004410898,0.01507518],"genre_scores_gemma":[0.9919922,0.00002108983,0.00210981,0.00521761,0.0001076241,0.00001741482,0.0002646924,0.000004687025,0.0002649011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04341788,"threshold_uncertainty_score":0.3196785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2190282709","doi":"10.1001/jamaoncol.2015.5208","title":"Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":343,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Germline; Genetics; Medicine; Germline mutation; Gene; Cancer; Allele; Mendelian inheritance; Exome sequencing; Biology; Phenotype; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.03058885808308488,"gpt":0.2934010566878006,"spread":0.2628121986047157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003904634,0.0001365194,0.0002310495,0.00006857877,0.00003084424,0.00002169987,0.0001617404,0.0002250504,0.00002627765],"category_scores_gemma":[0.0003889518,0.0001467222,0.00004746864,0.0001166888,0.00005558148,0.000006070763,0.0001724387,0.0001405406,0.00001588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003233546,"about_ca_system_score_gemma":0.001093147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005053219,"about_ca_topic_score_gemma":0.000750998,"domain_scores_codex":[0.9989133,0.00008243241,0.0002898162,0.0002929701,0.0000821295,0.0003392928],"domain_scores_gemma":[0.9993601,0.00003092765,0.0001157224,0.0002354245,0.0001101842,0.0001475969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003662105,0.0001182643,0.007550385,0.00001147589,0.00003679057,0.0002886173,0.0002864489,0.003552652,0.9824303,0.0001355673,0.003303567,0.001919653],"study_design_scores_gemma":[0.02127841,0.004113312,0.03527277,0.00008183128,0.0001592475,0.001577888,0.002579331,0.03009651,0.5887988,0.002231335,0.3118471,0.001963466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953589,0.0004208087,0.000775101,0.0003493575,0.0005335673,0.0001447134,0.00003105105,0.000009255305,0.002377256],"genre_scores_gemma":[0.99138,0.00004449808,0.00587193,0.001828636,0.0006590788,0.00001389817,0.00009120495,0.0000247457,0.00008602606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3936316,"threshold_uncertainty_score":0.5983158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294001741","doi":"10.1001/jamaoncol.2022.3829","title":"Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Cancer; Irinotecan; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04120636559404846,"gpt":0.3980314652659258,"spread":0.3568250996718773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007989455,0.0001806371,0.001297872,0.0001970426,0.0001838895,0.000005032902,0.0002402585,0.0001710011,0.004852505],"category_scores_gemma":[0.0005054429,0.0001424939,0.0002276839,0.0002289242,0.000211771,0.00004325623,0.0001598299,0.0003929534,0.00003230918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005009296,"about_ca_system_score_gemma":0.001242222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008688227,"about_ca_topic_score_gemma":0.00007447028,"domain_scores_codex":[0.9980475,0.0002436862,0.0004911909,0.0003389304,0.0003927843,0.0004859584],"domain_scores_gemma":[0.9979708,0.001050298,0.0002195666,0.0003825375,0.0002358835,0.0001409105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008274058,0.001291093,0.9000044,0.0001460781,0.001027615,0.0001212257,0.001233893,0.00001476756,0.002180535,0.00231229,0.03662018,0.04677389],"study_design_scores_gemma":[0.02033322,0.01431705,0.7072076,0.00002621683,0.0004371763,0.00009579468,0.001381245,0.0006148028,0.0004093138,0.001256555,0.2537382,0.0001828535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667569,0.001410674,0.00005013806,0.01940481,0.0003306445,0.00161914,0.0001091885,0.00003989544,0.01027856],"genre_scores_gemma":[0.9701468,0.001269274,0.00202519,0.005554672,0.0002456406,0.002413878,0.00006932471,0.00004458189,0.01823059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2171181,"threshold_uncertainty_score":0.9960572,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2613162682","doi":"10.1001/jamaoncol.2017.0751","title":"Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Retrospective cohort study; Androgen deprivation therapy; Oncology; Internal medicine; Prospective cohort study; Prostate; Subtyping; Metastasis; Cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03806270671449913,"gpt":0.350841259632572,"spread":0.3127785529180728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002539077,0.00006820288,0.0002588202,0.00005661078,0.00008452228,0.00001248552,0.00003089645,0.00005784862,0.000006691011],"category_scores_gemma":[0.0001429995,0.00005054535,0.00001578961,0.00004405766,0.0001120144,0.00007153869,0.00002901858,0.00004701527,1.743443e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001228986,"about_ca_system_score_gemma":0.0002593177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005380592,"about_ca_topic_score_gemma":0.000424795,"domain_scores_codex":[0.999465,0.00004867689,0.0001513091,0.0001462533,0.00008474418,0.0001040367],"domain_scores_gemma":[0.9992665,0.0001283766,0.0002402623,0.0001303902,0.0001706789,0.00006376565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003887478,0.0001727824,0.9151415,0.00002773535,0.0001381128,0.00001131866,0.001671277,0.00000111392,0.007188136,0.00002306335,0.0001473582,0.07159013],"study_design_scores_gemma":[0.003756804,0.003073771,0.9492278,0.0001229487,0.00007700391,0.000007086366,0.0001064938,0.00001158028,0.0419611,0.00003407618,0.001575633,0.00004577271],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984664,0.0006282078,0.000003506161,0.01385333,0.00002938449,0.0006427049,0.00007863211,0.000004977773,0.00009523964],"genre_scores_gemma":[0.9974144,0.001225064,0.0007928165,0.000284369,0.00003282509,0.0002064103,0.000008506226,0.000008114595,0.00002753022],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07154436,"threshold_uncertainty_score":0.2061179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898717093","doi":"10.1001/jamaoncol.2018.4628","title":"Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Immunotherapy; Adverse effect; Cancer; Head and neck cancer; Nivolumab; Ipilimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.02132207823139834,"gpt":0.3195066670134031,"spread":0.2981845887820048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003381502,0.0002176851,0.0007497742,0.0001716349,0.00005588786,0.00000836715,0.00008500717,0.0001042997,0.0004271466],"category_scores_gemma":[0.0001940454,0.0001145816,0.00003951506,0.0004533385,0.0006617668,0.00009258524,0.00003347273,0.0002029606,0.000005221498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000320357,"about_ca_system_score_gemma":0.0006628711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002530923,"about_ca_topic_score_gemma":0.003632761,"domain_scores_codex":[0.9984154,0.0002023527,0.0004742751,0.0003479788,0.0002712812,0.0002887732],"domain_scores_gemma":[0.998706,0.0003772835,0.0003043443,0.00026178,0.0002539226,0.00009661275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6839135,0.001821576,0.06570114,0.0001625552,0.0005776833,0.00005617364,0.004288066,9.669344e-7,0.000185074,0.00001138811,0.0003068433,0.242975],"study_design_scores_gemma":[0.113006,0.05989755,0.8158235,0.000907859,0.0003147213,0.00008124032,0.0008846591,0.00009561415,0.0008349899,0.000007628005,0.007909201,0.0002370408],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966209,0.0001080643,0.00005701741,0.0006608581,0.000120522,0.001215421,0.00002883072,0.0000198761,0.00116852],"genre_scores_gemma":[0.9958749,0.0001413886,0.002856996,0.0005764759,0.00006775508,0.00003689537,0.00002258253,0.00002878121,0.0003941987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7501224,"threshold_uncertainty_score":0.4676955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2907028960","doi":"10.1001/jamaoncol.2018.5904","title":"Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers","year":2019,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Hazard ratio; Meta-analysis; Internal medicine; Randomized controlled trial; Observational study; Clinical trial; Oncology; MEDLINE; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01836268428872953,"gpt":0.3204437840325803,"spread":0.3020810997438508,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005513769,0.0002397163,0.002293872,0.000204436,0.0000102834,0.000002389895,0.00006943511,0.0004882111,0.0000379687],"category_scores_gemma":[0.0001279228,0.0001761207,0.000243768,0.0002530791,0.00008600824,0.00003975018,0.00004229608,0.0003734284,0.000001139509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002168236,"about_ca_system_score_gemma":0.001348973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001290389,"about_ca_topic_score_gemma":0.0003978213,"domain_scores_codex":[0.9979614,0.0002208003,0.00107359,0.000284971,0.0002457956,0.0002134454],"domain_scores_gemma":[0.997556,0.0004669578,0.001596261,0.0002443887,0.00009767197,0.00003874293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002580703,0.0002049037,0.001751026,0.008724434,0.0006902503,0.00001124707,0.0004857327,0.000004697609,0.0002617241,0.000004821371,0.0000987222,0.9851817],"study_design_scores_gemma":[0.01237433,0.005002797,0.008336536,0.01259219,0.0008556556,0.00002690395,0.000238855,0.000003137284,0.0002267345,0.000002053071,0.9600863,0.000254456],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.105415,0.8919026,4.36493e-7,0.0001634847,0.000392156,0.001293661,0.00003233393,0.000007763476,0.0007925865],"genre_scores_gemma":[0.004314137,0.9949275,0.00009621368,0.00004877852,0.00006547457,0.00005230391,0.0000699898,0.00003166745,0.0003938835],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849273,"threshold_uncertainty_score":0.7181993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205809226","doi":"10.1001/jamaoncol.2021.6590","title":"Association of Daily Sitting Time and Leisure-Time Physical Activity With Survival Among US Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Sitting; Population; Cohort study; Cohort; National Health and Nutrition Examination Survey; Gerontology; Cancer; Cancer survivor; Demography; Physical therapy; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.009966207491442652,"gpt":0.2778777303757237,"spread":0.2679115228842811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006680519,0.0001416433,0.0006626216,0.00007260295,0.0001272322,0.00001055905,0.00007553911,0.0001204166,0.0004145203],"category_scores_gemma":[0.0000807388,0.0001292019,0.00007882518,0.0002860718,0.00009123021,0.00009831618,0.0001262056,0.0004677979,0.000005784173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007413056,"about_ca_system_score_gemma":0.0003233202,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01468489,"about_ca_topic_score_gemma":0.01275196,"domain_scores_codex":[0.9984083,0.0004272764,0.0001502198,0.0002953372,0.0004475229,0.0002713991],"domain_scores_gemma":[0.998767,0.0005279856,0.0003028464,0.0001639005,0.000143231,0.00009505151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001326352,0.0004284965,0.9547934,0.0000661365,0.0002963427,0.0000454349,0.002831862,0.0001183592,0.01527863,0.0000149295,0.001022583,0.02377751],"study_design_scores_gemma":[0.002690583,0.001630113,0.9757978,0.00002880182,0.0003452676,0.00001840755,0.0007541847,0.002314805,0.001806782,0.00001187533,0.01439859,0.0002027923],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922274,0.00005469192,0.000005375497,0.002265566,0.0002896688,0.0002610552,0.00009130217,0.00004557141,0.004759348],"genre_scores_gemma":[0.9952751,0.00001156399,0.00001799194,0.0001431567,0.0003302256,0.00007052073,0.0000297607,0.00002552303,0.004096196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02357471,"threshold_uncertainty_score":0.9918764,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3044088237","doi":"10.1001/jamaoncol.2020.2485","title":"Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"U.S. Department of Defense","keywords":"Medicine; Grading (engineering); Biopsy; Prostate cancer; Prostate; Second opinion; Prostate biopsy; Radiology; Tumor grade; Medical physics; Cancer; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03322866146935342,"gpt":0.3126263232890722,"spread":0.2793976618197188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008141733,0.00008781451,0.0003501192,0.00003479347,0.0000303841,0.00000433423,0.0000237113,0.00006577976,0.000054393],"category_scores_gemma":[0.00004704711,0.00007554644,0.00003533855,0.0000683017,0.00003895242,0.00003706617,0.00002635242,0.00007128893,0.00000119735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001816609,"about_ca_system_score_gemma":0.000140541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001428669,"about_ca_topic_score_gemma":0.00001670049,"domain_scores_codex":[0.9993119,0.00002494779,0.0002571051,0.0001950388,0.00008532014,0.0001257266],"domain_scores_gemma":[0.9994537,0.0001246764,0.0002020176,0.00004653834,0.00008898485,0.00008404563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003511207,0.0001503171,0.05059395,0.0001501187,0.0002713214,0.00001944327,0.007137123,0.00001765965,0.01556765,0.0000371452,0.0001752218,0.9255289],"study_design_scores_gemma":[0.009698225,0.002975098,0.1047078,0.000293886,0.0004326189,0.000009685631,0.001900429,0.005258931,0.7691957,0.0001005927,0.1052485,0.0001785107],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931239,0.001753677,0.001325345,0.002920542,0.00007879642,0.0005875886,0.00005972532,0.00001420299,0.0001361535],"genre_scores_gemma":[0.9168828,0.0007839234,0.08148539,0.0002614679,0.0001436274,0.0002396938,0.0001608303,0.00001655804,0.00002573321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9253504,"threshold_uncertainty_score":0.3080695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3030999222","doi":"10.1001/jamaoncol.2020.1271","title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Radiosurgery; Interquartile range; Lung cancer; Radiation therapy; Brain metastasis; Internal medicine; Prophylactic cranial irradiation; Oncology; Cohort; Retrospective cohort study; Cancer; Metastasis; Conventional PCI","retraction":null,"screen_n_in":null,"score":{"opus":0.09586448013135285,"gpt":0.4261814842082574,"spread":0.3303170040769045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002821763,0.0002014821,0.0008492894,0.0001431024,0.00008395426,0.00001197047,0.0001517033,0.000160803,0.0008393807],"category_scores_gemma":[0.004848471,0.0001708646,0.0002230457,0.0003271603,0.0001342346,0.00007746834,0.0000625632,0.0002444988,0.000004691682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051446,"about_ca_system_score_gemma":0.001680868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001871494,"about_ca_topic_score_gemma":0.0003822999,"domain_scores_codex":[0.9975182,0.0005329308,0.0004710554,0.0004133064,0.0006454981,0.000418981],"domain_scores_gemma":[0.9958144,0.002590252,0.00025631,0.0002501193,0.0008794246,0.0002094865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0032107,0.0003394235,0.007380934,0.001447448,0.001161245,0.00003222701,0.002334056,0.001033238,0.02289438,0.00002783545,0.855301,0.1048375],"study_design_scores_gemma":[0.01976219,0.003897871,0.003889667,0.0001840042,0.001069777,0.00001213299,0.0002545069,0.05200739,0.01290083,0.00006061726,0.9057356,0.0002254359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2455751,0.03400484,0.003082583,0.7101889,0.0004829718,0.004642719,0.000932708,0.00009288054,0.0009972929],"genre_scores_gemma":[0.9108083,0.003017512,0.009882783,0.06140883,0.005578314,0.005866725,0.0007765747,0.0002197363,0.002441268],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6652332,"threshold_uncertainty_score":0.919063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032917453","doi":"10.1001/jamaoncol.2020.1694","title":"Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer","year":2020,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Observational study; Hysterectomy; Randomized controlled trial; Meta-analysis; Radical Hysterectomy; Confounding; Stage (stratigraphy); Surgery; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1094907911900193,"gpt":0.4247986267123997,"spread":0.3153078355223804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003850704,0.0007423896,0.00564289,0.0002168928,0.00008009592,0.0001153594,0.000828251,0.001346229,0.003715829],"category_scores_gemma":[0.0007892549,0.0005274242,0.001170229,0.0006538673,0.0001908749,0.0001273368,0.0007510942,0.001010358,0.0003900594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001665294,"about_ca_system_score_gemma":0.004380254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008406164,"about_ca_topic_score_gemma":0.0009999287,"domain_scores_codex":[0.9958947,0.0005985778,0.001153849,0.001173859,0.0004267169,0.0007522984],"domain_scores_gemma":[0.9954701,0.002526553,0.0005217278,0.0004922207,0.0001966621,0.0007927439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007918804,0.0005247192,0.0005164347,0.01690818,0.001868977,0.001789937,0.0001071258,2.168287e-8,9.152321e-7,0.00008926381,0.003302626,0.966973],"study_design_scores_gemma":[0.01414063,0.005077075,0.0009622777,0.004257352,0.004161673,0.00008002645,0.00001825617,7.725981e-7,0.000004667725,0.00003328684,0.9708013,0.0004626612],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003016768,0.9758266,0.00001219358,0.005386582,0.001671969,0.006855459,0.00142483,0.00007183883,0.008448843],"genre_scores_gemma":[0.0001894783,0.9773886,0.00113302,0.004498302,0.003609705,0.008575133,0.0005177623,0.0001660065,0.00392203],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9674987,"threshold_uncertainty_score":0.9999502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4393037627","doi":"10.1001/jamaoncol.2024.0057","title":"Neoadjuvant Chemoimmunotherapy for NSCLC","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"University of Texas MD Anderson Cancer Center; Eisai; Regeneron Pharmaceuticals; Amgen; Johns Hopkins University; AstraZeneca","keywords":"Medicine; Chemoimmunotherapy; Neoadjuvant therapy; Oncology; Internal medicine; Chemotherapy; Cancer; Cyclophosphamide; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.07003444763824695,"gpt":0.4524353575357795,"spread":0.3824009098975325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002015426,0.0004002879,0.002489451,0.0001606437,0.0000381811,0.0000318065,0.0001292906,0.0007163836,0.0002430519],"category_scores_gemma":[0.00002991627,0.0002472597,0.001123243,0.0001656118,0.00005224034,0.00002129911,0.00003248208,0.0004092265,0.0005410574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001987618,"about_ca_system_score_gemma":0.001376233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002192796,"about_ca_topic_score_gemma":0.00001352849,"domain_scores_codex":[0.9984562,0.00004922352,0.0005221395,0.0005209345,0.0001194959,0.0003320432],"domain_scores_gemma":[0.9988415,0.0003567118,0.0001899756,0.000439158,0.00006684334,0.0001057952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005930051,0.0002697142,8.055061e-7,0.01905839,0.001352644,0.0001838516,0.0000489833,9.320681e-9,1.850633e-7,0.0005570998,0.1264868,0.8519822],"study_design_scores_gemma":[0.00214318,0.001688837,0.000002285305,0.01730382,0.007840467,0.000375548,0.000006298084,0.000002071558,0.000001733369,0.0001307613,0.9703074,0.0001976112],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[9.323931e-7,0.9842067,0.00001725259,0.003965616,0.001629059,0.002675114,0.0001180274,0.00009529795,0.007292004],"genre_scores_gemma":[0.000001320797,0.9865857,0.0006704776,0.001383284,0.001563567,0.003540076,0.0003892669,0.000123216,0.005743043],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8517846,"threshold_uncertainty_score":0.999998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810247444","doi":"10.1001/jamaoncol.2018.1977","title":"Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Toronto General Hospital; Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Oncology; Glioma; Radiation therapy; Internal medicine; Glioblastoma; Methylation; Cancer research; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.007310149578843544,"gpt":0.2622094238837329,"spread":0.2548992743048893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002371294,0.000191441,0.0006467819,0.0002184388,0.00004572285,0.00001439265,0.0000307763,0.0001758917,0.00003279939],"category_scores_gemma":[0.0000699956,0.0001083755,0.00002511214,0.0003143581,0.0001109748,0.0001185198,0.00001063775,0.0001233151,0.000002249097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005716363,"about_ca_system_score_gemma":0.00009610477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001555946,"about_ca_topic_score_gemma":0.003850252,"domain_scores_codex":[0.9986757,0.0002139216,0.0002603438,0.0002887972,0.0002818443,0.000279388],"domain_scores_gemma":[0.9987283,0.0003092107,0.0003780323,0.000185367,0.0003073072,0.00009176753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004285759,0.001209519,0.9806817,0.00001219447,0.0007720955,0.00004432649,0.0004082323,0.000005275367,0.0003884789,0.00002164868,0.00006324301,0.01210754],"study_design_scores_gemma":[0.03331992,0.0166228,0.9451328,0.00004280345,0.0003585241,0.000005073616,0.00005447752,0.00002769629,0.003900301,0.00001416258,0.0004037408,0.0001177086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978316,0.0000440132,0.00003202435,0.001032477,0.00004755165,0.0007301553,0.00003848956,0.00002561836,0.0002180549],"genre_scores_gemma":[0.9969912,0.00003541797,0.002623274,0.0001147489,0.00004407387,0.00005032193,0.00007287444,0.0000276997,0.00004041689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0355489,"threshold_uncertainty_score":0.4419425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3137427440","doi":"10.1001/jamaoncol.2021.0379","title":"Evolution of the Randomized Clinical Trial in the Era of Precision Oncology","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; NOSM University; Kingston Health Sciences Centre; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; Surrogate endpoint; Breast cancer; Oncology; Clinical endpoint; Colorectal cancer; Cohort; Lung cancer; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.5062045424251019,"gpt":0.6209226704404257,"spread":0.1147181280153238,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05315469,0.0001324694,0.002234052,0.00004143551,0.00003887423,0.000007085114,0.0006133611,0.0008016671,0.0002963057],"category_scores_gemma":[0.6388645,0.00006850441,0.0007018838,0.000443751,0.001042392,0.00003077283,0.0002822258,0.001171999,0.000006891917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001851862,"about_ca_system_score_gemma":0.001152006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003231146,"about_ca_topic_score_gemma":0.0001136451,"domain_scores_codex":[0.9402244,0.05465157,0.003985956,0.000373084,0.0005025108,0.0002624496],"domain_scores_gemma":[0.498038,0.4993135,0.001477172,0.000783174,0.0003433854,0.00004478564],"domain_codex":null,"domain_gemma":"methods","domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.4461532,0.003525533,0.0002978434,0.00006444454,0.0001370974,0.00003062447,0.0005928125,0.000006048721,0.00021824,0.3619189,0.005017311,0.1820379],"study_design_scores_gemma":[0.3391635,0.0009580592,0.00108363,0.00005998772,0.0001985243,0.00001194893,0.0002116693,0.0002299295,0.0002146071,0.6550515,0.002765422,0.000051153],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8396345,0.0003715813,0.08502742,0.02617938,0.01192777,0.006295986,0.00006759122,0.00003227143,0.03046345],"genre_scores_gemma":[0.5210251,0.0002016636,0.4763527,0.0009637403,0.001099841,0.0002123767,0.000001346033,0.00002051707,0.000122685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5857098,"threshold_uncertainty_score":0.9749765,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310566600","doi":"10.1001/jamaoncol.2022.5610","title":"Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Aptitude Health; Eisai; National Breast Cancer Foundation; Seagen; G1 Therapeutics; Daiichi-Sankyo; MacroGenics; Silverback Therapeutics; Puma Biotechnology; Medac; Ipsen; OncoSec Medical; Syndax Pharmaceuticals; BioMarin Pharmaceutical; Mylan; Ionis Pharmaceuticals; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Vertex Pharmaceuticals; Foundation Medicine; Genomic Health; Breast Cancer Research Foundation; Jounce Therapeutics; Celgene; Genentech; Veracyte; Amgen; Radius Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Yale University; Sanofi; GlaxoSmithKline; Carrick Therapeutics; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer","keywords":"Capecitabine; Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Placebo; Oncology; Breast cancer; Pertuzumab; Cancer; Colorectal cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.009678729924896167,"gpt":0.2817659237388417,"spread":0.2720871938139456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005315593,0.0002827587,0.0007541502,0.000311913,0.0001109044,0.00001684671,0.0000692821,0.00005067558,0.0002760401],"category_scores_gemma":[0.00006193767,0.0001922696,0.00004911942,0.0004398199,0.0001173421,0.0001347871,0.00004242034,0.0002242774,8.965692e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001278129,"about_ca_system_score_gemma":0.0004633731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001215194,"about_ca_topic_score_gemma":0.003783721,"domain_scores_codex":[0.9978235,0.0005835888,0.0003858971,0.0004993913,0.0002811832,0.0004263741],"domain_scores_gemma":[0.9985288,0.0008105739,0.0002310212,0.0001779549,0.0001230331,0.0001286205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06097251,0.0130641,0.7169603,0.0002841293,0.00138217,0.0005911545,0.003549921,0.000307211,0.00006379022,0.0008314272,0.002156978,0.1998363],"study_design_scores_gemma":[0.08634218,0.02313877,0.8856732,0.0001758666,0.0006592626,0.000223763,0.001127045,0.0002548317,0.00005056886,0.00006979308,0.002019831,0.0002649215],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845714,0.0002317324,0.0001393122,0.008986842,0.00004495642,0.00402422,0.00182403,0.00002439652,0.0001531337],"genre_scores_gemma":[0.9928613,0.00002148421,0.001995229,0.001158312,0.00001984817,0.003015317,0.0006832056,0.00004865134,0.0001966374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1995714,"threshold_uncertainty_score":0.7840527,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210689349","doi":"10.1001/jamaoncol.2021.6744","title":"Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; David Geffen School of Medicine, University of California, Los Angeles; European Regional Development Fund; National Cancer Institute; Medisinske fakultet, Universitetet i Oslo; Servicio Gallego de Salud; Universitätsklinikum Hamburg-Eppendorf; Scottish Government; KWF Kankerbestrijding; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Instituto de Salud Carlos III; Freistaat Sachsen; Russian Academy of Sciences; Medical Research Council; European Commission; Canadian Institutes of Health Research; Directorate for Biological Sciences; National Institutes of Health; Université de Versailles Saint-Quentin-en-Yvelines; Universitätsklinikum Köln; Akershus Universitetssykehus; National University Health System; Agency for Science, Technology and Research; Universidad de La Sabana; Pomorski Uniwersytet Medyczny W Szczecinie; Institut Gustave-Roussy; Universität zu Köln; Fondazione Italiana per la Ricerca sul Cancro; Medizinischen Hochschule Hannover; Kreftforeningen; Institut National Du Cancer; Leids Universitair Medisch Centrum; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; Deutsche Krebshilfe; National Health and Medical Research Council; Universiti Malaya; Norges Forskningsråd; National Medical Research Council; Stockholms Läns Landsting; Sundhed og Sygdom, Det Frie Forskningsråd; Saint Petersburg State University; Kuopion Yliopistollinen Sairaala; University of Toronto; Pontificia Universidad Javeriana; King's College London; Gentofte Hospital; Deutsche Forschungsgemeinschaft; Deutsche Gesetzliche Unfallversicherung; Alexander von Humboldt-Stiftung; Cancerfonden; Cancer Council Victoria; University of Melbourne; Robert Bosch Stiftung; Programme Grants for Applied Research; Manchester Biomedical Research Centre; Monash University; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Universiteit Leiden; Cancer Research Institute; University of Crete; Institut National de la Santé et de la Recherche Médicale; Institute of Genetics; Wellcome Trust; Agence Nationale de la Recherche; Lunds Universitet; Faculty of Health and Medical Sciences, University of Western Australia; Cancer Research UK; National University of Singapore; National Research Foundation Singapore; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Research Foundation; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Genome Institute of Singapore; National Breast Cancer Foundation; QIMR Berghofer Medical Research Institute; Research Promotion Foundation; Engineering and Physical Sciences Research Council; Fondation de France; University of Cambridge; Government of Canada; Breast Cancer Research Trust; Fondation du cancer du sein du Québec; Duke-NUS Medical School; Huntsman Cancer Institute; Scottish Funding Council; Instituto de Investigación Sanitaria de Santiago de Compostela; Deutsches Krebsforschungszentrum; Helsingin Yliopisto; Genome Canada; University of California, San Diego; Universitetet i Oslo; University of Oxford; Cancer Council NSW; Susan G. Komen for the Cure","keywords":"Medicine; Germline; Breast cancer; Gene; Germline mutation; Cancer; Pathology; Oncology; Genetics; Internal medicine; Mutation; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01116760055394735,"gpt":0.2814819573539547,"spread":0.2703143568000074,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006878763,0.0001506456,0.0003249119,0.00009969007,0.000081609,0.000004128618,0.0002737142,0.0001976491,0.0004739543],"category_scores_gemma":[0.00008923937,0.0001496774,0.00006798443,0.0003482142,0.0002008932,0.000004329063,0.0002736161,0.0002479853,0.000001279642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005386086,"about_ca_system_score_gemma":0.001238831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001968023,"about_ca_topic_score_gemma":0.002872329,"domain_scores_codex":[0.9980927,0.0005786116,0.0003798884,0.0004805894,0.0001541436,0.000314055],"domain_scores_gemma":[0.9990799,0.00005381616,0.0002814053,0.0003680977,0.0001689743,0.0000478018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0009681126,0.0007974157,0.2328358,0.00001915326,0.0001412628,0.0001766092,0.0003464126,0.006195227,0.7343971,0.00005040515,0.001472562,0.02259994],"study_design_scores_gemma":[0.003537968,0.001471052,0.9747927,0.000013355,0.00005568126,0.000469709,0.0005547575,0.000261906,0.01165548,0.0001373829,0.00673685,0.0003131884],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961916,0.0008271458,0.00005943928,0.001404652,0.0002524179,0.0002520778,0.0007109829,0.00001021431,0.0002914282],"genre_scores_gemma":[0.9979852,0.0001303056,0.0003372123,0.0006856595,0.0001168117,0.0003159027,0.0002414119,0.00002774435,0.0001597063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7419569,"threshold_uncertainty_score":0.6103669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2395076114","doi":"10.1001/jamaoncol.2016.0732","title":"Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Underweight; Body mass index; Colorectal cancer; Population; Hazard ratio; Retrospective cohort study; Internal medicine; Cancer; Cohort study; Surgery; Overweight; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01877962362137314,"gpt":0.3317732007112069,"spread":0.3129935770898338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001020901,0.00008412952,0.0004673509,0.0001851056,0.00001342069,0.000002949814,0.00002850959,0.0001247302,0.0001188948],"category_scores_gemma":[0.00003170275,0.0000500012,0.00004102508,0.0003576857,0.0001438665,0.00005262073,0.00002199129,0.00008549878,2.388678e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003514202,"about_ca_system_score_gemma":0.0001788734,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007712523,"about_ca_topic_score_gemma":0.01527268,"domain_scores_codex":[0.99927,0.0000429361,0.0002027991,0.0001847969,0.000137788,0.0001616379],"domain_scores_gemma":[0.99954,0.00007312025,0.0001278588,0.0001018823,0.00008221758,0.00007495734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000940908,0.0001463698,0.9851211,0.0000117346,0.0005545807,0.00001507499,0.000120102,0.00002020251,0.001617615,0.000008048657,0.00001194596,0.01143234],"study_design_scores_gemma":[0.003965344,0.0006396867,0.9936852,0.00003243512,0.0007326858,7.237854e-7,0.0000327975,0.000452253,0.0002163538,0.000007694,0.0001663606,0.00006845905],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992733,0.00003533894,0.00007351685,0.0001351367,0.00007644633,0.000186608,0.00006345985,0.000005967935,0.0001502527],"genre_scores_gemma":[0.999764,0.00004043064,0.00003351978,0.00007949735,0.00003845367,0.00001351288,0.00001006566,0.000007486468,0.00001307735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01136388,"threshold_uncertainty_score":0.9988952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3030472743","doi":"10.1001/jamaoncol.2020.2218","title":"Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Renal cell carcinoma; Population; Oncology; Clinical endpoint; Cabozantinib; Expanded access; Clinical trial; Urology; Surgery; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.02354514024351321,"gpt":0.2551513649527695,"spread":0.2316062247092563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001231657,0.0002685994,0.0008432578,0.0001651611,0.00003136725,0.000007029443,0.000166452,0.0002500257,0.0002406189],"category_scores_gemma":[0.0001587309,0.0002167958,0.0001393265,0.0003749072,0.0001722668,0.00007014907,0.0001132275,0.000434984,0.00006351498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003049785,"about_ca_system_score_gemma":0.0004581036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001179309,"about_ca_topic_score_gemma":0.00002212145,"domain_scores_codex":[0.9978889,0.0002446597,0.0005887757,0.0004589998,0.0003781378,0.000440499],"domain_scores_gemma":[0.9984536,0.0003560475,0.0002616015,0.0003541906,0.0002185739,0.0003560233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01103727,0.001861601,0.9694324,0.0002639503,0.0000768705,0.001263002,0.001593794,0.00003564797,0.004146743,0.00006240573,0.001815385,0.008410908],"study_design_scores_gemma":[0.02590331,0.01846907,0.9320972,0.00006836007,0.0001809922,0.00002535037,0.0001819828,0.00003345466,0.01414863,0.000007121727,0.00869983,0.0001846942],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805813,0.0001517166,0.000005362303,0.002069949,0.00006636912,0.0009446933,0.00003662228,0.00003591204,0.01610801],"genre_scores_gemma":[0.9955845,0.00001290525,0.001692662,0.002114681,0.0002046831,0.0000347752,0.0002207158,0.00004566837,0.00008933664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03733523,"threshold_uncertainty_score":0.8840678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2800412330","doi":"10.1001/jamaoncol.2018.0211","title":"Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among <i>BRCA1</i> Mutation Carriers","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":172,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Oophorectomy; Ovarian cancer; Prospective cohort study; Internal medicine; Hormone replacement therapy (female-to-male); Gynecology; Family history; Cancer; Proportional hazards model; Oncology; BRCA mutation; Cohort; Cohort study; Obstetrics; Surgery; Hysterectomy; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.006555885125884231,"gpt":0.2759702554422717,"spread":0.2694143703163874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002624684,0.0001676768,0.0001604712,0.00005408646,0.0001292078,0.00003145012,0.000110758,0.0002895971,0.0001746205],"category_scores_gemma":[0.00003626305,0.0001565511,0.00004963302,0.0001167083,0.0004381622,0.000009885847,0.00008332292,0.0001353754,0.00001055245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002019789,"about_ca_system_score_gemma":0.000294363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004640937,"about_ca_topic_score_gemma":0.001107101,"domain_scores_codex":[0.9987928,0.0001496137,0.0002131605,0.0004703292,0.0001105884,0.0002635163],"domain_scores_gemma":[0.9991971,0.00002118082,0.0001571724,0.0003089134,0.0002164277,0.00009920933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.008848138,0.0002270231,0.2468937,0.00002022433,0.000863409,0.00003624618,0.003427458,0.0001000902,0.1962066,0.00002278908,0.09273612,0.4506182],"study_design_scores_gemma":[0.005440853,0.002157555,0.620205,0.00001120703,0.00007807695,0.0001212688,0.0004498849,0.0001721759,0.07133625,0.0001319264,0.299493,0.0004028009],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931433,0.00334529,0.0003110105,0.001046589,0.0004797254,0.0003072813,0.0001375099,0.00001737311,0.001211871],"genre_scores_gemma":[0.9925317,0.003258572,0.0007586291,0.001632752,0.001032968,0.0004101332,0.000046461,0.00003115752,0.0002976846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4502154,"threshold_uncertainty_score":0.638397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386501692","doi":"10.1001/jamaoncol.2023.2960","title":"The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of British Columbia","funders":"Division of Mathematical Sciences; National Heart, Lung, and Blood Institute; Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences; Leibniz-Gemeinschaft; National Health and Medical Research Council; Medical Research Council; University of Florida Health; Samsung; King Saud University; Universitätsklinikum Heidelberg; Monash University Malaysia; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Institute for Advanced Studies in Basic Sciences; University of Colombo; Xiamen University; National Institute for Medical Research Development; Yasuj University of Medical Sciences; University of Washington; Wuhan University; Sigrid Juséliuksen Säätiö; Guilan University of Medical Sciences; Masarykova Univerzita; Shahid Beheshti University of Medical Sciences; Hacettepe Üniversitesi; Birjand University of Medical Sciences; Zhejiang University; Kerman University of Medical Sciences; Rajarata University of Sri Lanka; Ain Shams University; Shiraz University of Medical Sciences; College of Medicine, Korea University; World Health Organization; Mazandaran University of Medical Sciences; King Abdulaziz University; Isfahan University of Medical Sciences; Pasteur Institute of Iran; Universitatea din București; Alexandria University; Università degli Studi di Padova; Korea University; Oulun Yliopisto; Pohang University of Science and Technology; University of Gondar; Massachusetts General Hospital; Lékařská fakulta, Masarykova univerzita; Radboud Universiteit; Imperial College London; Shiraz University; National Natural Science Foundation of China; Monash University; Karolinska Institutet; National Institute for Health and Care Research; University of Queensland; Amity University; Mashhad University of Medical Sciences; Public Health England; Royal College of Surgeons in Ireland; University of Leeds; Public Health Foundation of India; St. Jude Children's Research Hospital; Indian Council of Medical Research; National University of Singapore; University of Warwick; Coventry University; European Commission; National Human Genome Research Institute; Macquarie University; JSS Academy of Higher Education and Research; Dire Dawa University; Politechnika Gdańska; University of Exeter; Moderna; Kasturba Medical College, Manipal; Kermanshah University of Medical Sciences; Vanderbilt University; U.S. Department of Veterans Affairs; Rafsanjan University of Medical Sciences; Louisiana State University; Seres Therapeutics; Wellcome Trust; Johns Hopkins University; Amarin Corporation; Iran University of Medical Sciences; Bill and Melinda Gates Foundation; Instituto de Salud Carlos III; Università degli Studi di Milano; Saveetha Dental College; National Defense Medical College; Intuitive Surgical; Sveučilište u Zagrebu; Social Science Research Council; National Cancer Institute; University of South Carolina; Bournemouth University; The Wellcome Trust DBT India Alliance; Flinders University; Universidade Federal do Rio Grande do Sul; Harvard University; Università di Catania; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Anglia Ruskin University; Tehran Heart Center; National Institutes of Health; University of Veterinary and Animal Sciences; Florida Department of Health; King Abdullah University of Science and Technology; Department of Biotechnology, Ministry of Science and Technology, India; Jordan University of Science and Technology; McMaster University; School of Medicine, University of Alabama at Birmingham; Plastic Surgery Foundation","keywords":"Medicine; Cancer; MEDLINE; Family medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07646881709137004,"gpt":0.4355770112345375,"spread":0.3591081941431675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003032411,0.0002118696,0.001439443,0.00007714684,0.0001148032,0.00002213137,0.00006924348,0.0002967038,0.000008165648],"category_scores_gemma":[0.0002934381,0.0001335665,0.00005228705,0.0001967523,0.0007119727,0.0000503356,0.00013643,0.0002583496,0.000001493941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003563887,"about_ca_system_score_gemma":0.00126639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002699987,"about_ca_topic_score_gemma":0.01003281,"domain_scores_codex":[0.9987251,0.000107212,0.0004411716,0.0002880113,0.0002300675,0.0002084275],"domain_scores_gemma":[0.9985868,0.0008093794,0.0002022223,0.00009087934,0.0002400244,0.00007074109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002019636,0.00003198933,0.002442237,0.01223512,0.0004725046,0.00005999931,0.0006584783,8.250174e-8,2.085663e-7,0.003130518,0.06106101,0.9197059],"study_design_scores_gemma":[0.001006935,0.0003478747,0.001556512,0.005508623,0.0002917955,0.0001321548,0.0002559644,0.000004472824,9.838881e-8,0.0002878958,0.9904998,0.0001079036],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007938356,0.9835658,6.338002e-8,0.01378203,0.0003496068,0.0004565059,0.0003100595,0.00001479664,0.0007273029],"genre_scores_gemma":[0.00007497949,0.9981857,0.00002735187,0.0004684152,0.0006261779,0.0002190006,0.00002491486,0.00001553253,0.0003579109],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9294388,"threshold_uncertainty_score":0.5598546,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810342468","doi":"10.1001/jamaoncol.2018.1812","title":"Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Bausch Health (Canada); London Health Sciences Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Metastatic breast cancer; Taxane; Internal medicine; Adverse effect; Breast cancer; Pharmacokinetics; Oncology; Pertuzumab; Cancer; Response Evaluation Criteria in Solid Tumors; Capecitabine; Gastroenterology; Pharmacology; Progressive disease; Chemotherapy; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02518294945205386,"gpt":0.3936798830373113,"spread":0.3684969335852575,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000597553,0.0003237587,0.0008998061,0.0002999347,0.0001019024,0.0000271537,0.0002594642,0.0001938114,0.002093082],"category_scores_gemma":[0.0002441479,0.0002570119,0.00007123583,0.001004396,0.0007290912,0.000179502,0.0001045751,0.0008035024,0.0001973724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001891719,"about_ca_system_score_gemma":0.003271229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001896861,"about_ca_topic_score_gemma":0.01225003,"domain_scores_codex":[0.9969932,0.0003697681,0.000521815,0.0006676789,0.0005530389,0.0008945319],"domain_scores_gemma":[0.9976542,0.0005241146,0.0001828306,0.0005234793,0.0007594021,0.0003559607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06176285,0.00739858,0.1250909,0.00106195,0.00126712,0.00644448,0.01153335,0.00008649291,0.03291227,0.001242523,0.04656032,0.7046392],"study_design_scores_gemma":[0.03933163,0.03475713,0.8255426,0.002024311,0.0004005368,0.002508419,0.002980037,0.0008116039,0.009208158,0.0003481608,0.08122258,0.0008648823],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.932335,0.0004042556,0.0001684881,0.03979486,0.0005104773,0.001940884,0.0001964744,0.0001096114,0.02453992],"genre_scores_gemma":[0.9876527,0.0001884541,0.004045174,0.005353951,0.0005134426,0.0005633305,0.00005509436,0.00008678227,0.001541037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7037743,"threshold_uncertainty_score":0.9999882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770798942","doi":"10.1001/jamaoncol.2017.3776","title":"Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Drug Research and Development; University Hospital; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Response Evaluation Criteria in Solid Tumors; Internal medicine; Cervical cancer; Oncology; Cancer; Immunotherapy; Clinical trial; Phases of clinical research","retraction":null,"screen_n_in":null,"score":{"opus":0.02260364414613854,"gpt":0.3199594308553428,"spread":0.2973557867092043,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006189956,0.0001290746,0.0005599015,0.00008612462,0.0001260164,0.00001805473,0.00008288405,0.0001262398,0.0001712009],"category_scores_gemma":[0.00008301331,0.00008209154,0.00002620066,0.0001054037,0.0002078733,0.0001314733,0.00003692803,0.0002572871,0.000001303473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008591096,"about_ca_system_score_gemma":0.0003094592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006954953,"about_ca_topic_score_gemma":0.003015389,"domain_scores_codex":[0.9989133,0.0001546611,0.0002741984,0.000227167,0.0001829199,0.000247678],"domain_scores_gemma":[0.9989665,0.0001401567,0.0004811679,0.0002653254,0.00007639725,0.00007047848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2178663,0.001357901,0.5452014,0.0003777521,0.001022088,0.0005090098,0.00336068,0.000001339614,0.03741707,0.00006529182,0.0001896907,0.1926315],"study_design_scores_gemma":[0.02202309,0.007453315,0.9656861,0.0001408179,0.0001199008,0.00008071715,0.0002797508,0.00003366364,0.0009363908,0.00002046082,0.003118061,0.0001077308],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946479,0.00008728915,0.000005019642,0.003213812,0.00006216668,0.0004106018,0.00001624314,0.00001209757,0.001544843],"genre_scores_gemma":[0.9989622,0.0001454032,0.0001446795,0.0001686667,0.00002424662,0.00003059718,0.000005884184,0.0000133157,0.0005050718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4204847,"threshold_uncertainty_score":0.3347596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2175480754","doi":"10.1001/jamaoncol.2015.4685","title":"PD-L1 Testing in Cancer","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1275433939562716,"gpt":0.3985948787585825,"spread":0.2710514848023109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003556239,0.00006502014,0.0001947502,0.00007624747,0.00001361356,0.000005399941,0.00005041582,0.0001321264,0.0001682358],"category_scores_gemma":[0.0002544283,0.00005410543,0.00002958495,0.0002527772,0.00005905236,0.00004075599,0.00002086822,0.0001673355,0.00003004195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006117867,"about_ca_system_score_gemma":0.0007012192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002656299,"about_ca_topic_score_gemma":0.001082699,"domain_scores_codex":[0.9993701,0.00004463793,0.0001779381,0.0001319093,0.00009008239,0.0001853109],"domain_scores_gemma":[0.9995781,0.0001010119,0.00005353067,0.0001102178,0.00007755173,0.00007956524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003890615,0.0002427819,0.2117497,0.00002934516,0.00004834353,0.0002929324,0.001048976,0.00001189426,0.01685896,0.00003896666,0.04099822,0.7247893],"study_design_scores_gemma":[0.008962834,0.001289232,0.3354501,0.00009689325,0.00002330528,0.0001699247,0.0004362666,0.0002628586,0.0010124,0.0001339864,0.6520588,0.0001034269],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9222242,0.001689615,0.000007546201,0.01292841,0.0005428139,0.000179719,0.000002428047,0.00003739844,0.06238792],"genre_scores_gemma":[0.9891535,0.00009040454,0.001255476,0.007346345,0.0004648891,0.00005682861,0.000004083371,0.00001274788,0.00161571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7246858,"threshold_uncertainty_score":0.4015547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805212882","doi":"10.1001/jamaoncol.2018.2254","title":"Association of Exercise With Mortality in Adult Survivors of Childhood Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hospital for Sick Children; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Cancer; National Death Index; Population; Cohort study; Internal medicine; Hazard ratio; Incidence (geometry); Mortality rate; Pediatrics; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01855804234400553,"gpt":0.3345377270750343,"spread":0.3159796847310287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001073069,0.0001494421,0.0008712498,0.0001580942,0.0000222092,0.000003177274,0.0001292318,0.0003012605,0.0002705536],"category_scores_gemma":[0.0005577089,0.0001311755,0.00008579787,0.0004615624,0.0002052498,0.00009242499,0.00004609007,0.0002726027,0.000008114118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004481927,"about_ca_system_score_gemma":0.000754066,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0277409,"about_ca_topic_score_gemma":0.1144139,"domain_scores_codex":[0.9980048,0.0002285623,0.0006897959,0.0002888064,0.000503362,0.0002846538],"domain_scores_gemma":[0.9979084,0.0002534381,0.0006969686,0.0003601542,0.0006828562,0.00009816317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007308076,0.0009158122,0.9824528,0.0002621648,0.0002152145,0.000008169316,0.007151234,0.00000516899,0.0003708129,0.0001204624,0.001661152,0.006106208],"study_design_scores_gemma":[0.004744931,0.001399487,0.9846377,0.0006074903,0.0002181277,0.00000508886,0.00088164,0.00002583862,0.006008901,0.0001136813,0.001232745,0.0001243985],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879553,0.0001364358,0.00001675518,0.005911215,0.0003230587,0.0004854516,0.00005109537,0.00002639689,0.005094341],"genre_scores_gemma":[0.9976777,0.0002249483,0.0005002502,0.0009766442,0.0003036158,0.00004597189,0.00001656133,0.00002166438,0.0002326422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08667295,"threshold_uncertainty_score":0.9787335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385294431","doi":"10.1001/jamaoncol.2023.1830","title":"Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Physical Activity and Health","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Incidence (geometry); Physical activity; Cancer; Internal medicine; Gerontology; Physical therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.03467971875067961,"gpt":0.381301809719473,"spread":0.3466220909687934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001665615,0.0001314066,0.0005157202,0.00007898774,0.0001099778,0.00001523743,0.00006658488,0.0001521466,0.00001480345],"category_scores_gemma":[0.0002078985,0.0001126025,0.00006692098,0.000259633,0.0002030238,0.000226807,0.0001621729,0.0005433466,0.00007632386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002690876,"about_ca_system_score_gemma":0.0002285507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002267179,"about_ca_topic_score_gemma":0.0006904601,"domain_scores_codex":[0.9989107,0.00009385622,0.0001173834,0.0003389968,0.0001793331,0.0003597625],"domain_scores_gemma":[0.9989218,0.0005133416,0.00009268997,0.0001698562,0.00006073735,0.0002415899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001082853,0.001343821,0.03537824,0.0002686446,0.00004243786,0.0003556452,0.003281522,0.000007530309,0.01442256,0.00009769139,0.001785777,0.9419333],"study_design_scores_gemma":[0.001611647,0.001306404,0.9792114,0.0003121334,0.00005979879,0.00004893218,0.0002406029,0.01217721,0.002491958,0.0002701518,0.00213286,0.0001368696],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891844,0.00002790337,0.00002934072,0.009282652,0.0002002362,0.0002953896,0.000008650542,0.0001313677,0.0008400291],"genre_scores_gemma":[0.9978543,0.0002628884,0.00004830927,0.0007460177,0.0007708061,0.00007194337,0.00000453182,0.0000166756,0.0002245628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9438332,"threshold_uncertainty_score":0.4591798,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210203927","doi":"10.1001/jamaoncol.2021.4398","title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline <i>TP53</i> Variant Data Set","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Li–Fraumeni syndrome; Germline; Genetics; Phenotype; Cancer; Medicine; Germline mutation; Biology; Gene; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.03520636438146082,"gpt":0.3412794353095997,"spread":0.3060730709281389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004502365,0.0001228157,0.0004256281,0.0002152401,0.00003734096,0.0000140663,0.0004866732,0.0002050145,0.001255323],"category_scores_gemma":[0.0004905131,0.00009565311,0.0001782718,0.0008723059,0.00008129999,0.00006586788,0.0002723022,0.0003871631,0.00001439484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002853932,"about_ca_system_score_gemma":0.0009067114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001413741,"about_ca_topic_score_gemma":0.00100147,"domain_scores_codex":[0.9983811,0.000248717,0.0003518342,0.0004627608,0.0003691827,0.000186338],"domain_scores_gemma":[0.997665,0.0001644697,0.0001967786,0.001727678,0.0001493596,0.00009666035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01033309,0.01759194,0.07153662,0.0002840133,0.02900251,0.01912333,0.002783591,0.07929838,0.4824073,0.01554865,0.1066786,0.165412],"study_design_scores_gemma":[0.006903475,0.001299631,0.09398179,0.00009769927,0.004873795,0.0003504117,0.0001326507,0.4436319,0.023199,0.0001226193,0.4251522,0.0002548446],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7618376,0.0002842135,0.01187358,0.1566494,0.004129043,0.0008450885,0.00318087,0.000132474,0.06106772],"genre_scores_gemma":[0.9851446,0.00004195349,0.001425665,0.01009077,0.0003575932,0.000009566926,0.002500116,0.00002202259,0.0004077324],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4592083,"threshold_uncertainty_score":0.9996577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205157273","doi":"10.1001/jamaoncol.2021.7148","title":"Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease","year":2022,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Extramammary Paget's disease; Biopsy; Radiation therapy; Dermatology; Disease; Surgery; Radiology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.6527709803475009,"gpt":0.6188556866096045,"spread":0.03391529373789637,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003850153,0.0004146943,0.002766655,0.0002172736,0.0001761815,0.00003001627,0.0003782077,0.0006775047,0.002134652],"category_scores_gemma":[0.09514148,0.000323333,0.001900644,0.0003304533,0.0001650106,0.0001415272,0.0001939396,0.001364012,0.00007413825],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008482655,"about_ca_system_score_gemma":0.01413284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002540913,"about_ca_topic_score_gemma":0.000008401082,"domain_scores_codex":[0.9949411,0.001268186,0.002061227,0.0008498851,0.0004507573,0.0004288527],"domain_scores_gemma":[0.9711077,0.0254655,0.0009600169,0.0009894113,0.0008649864,0.0006124018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008274297,0.0003786728,0.000006202072,0.00644296,0.0001483993,0.00105838,0.000003983946,8.055869e-7,2.201901e-8,0.00006766195,0.3864941,0.6045714],"study_design_scores_gemma":[0.001705979,0.001664076,0.00002709558,0.009765025,0.008514116,0.0004463995,0.00003276905,0.0000626379,1.346224e-8,0.00004608333,0.9774414,0.0002944096],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[4.336122e-7,0.9471779,0.0005510821,0.04381394,0.002711442,0.002918857,0.0002735349,0.00009140297,0.002461443],"genre_scores_gemma":[2.291027e-7,0.9258772,0.01741824,0.04567168,0.005542363,0.0026229,0.0008065349,0.00009149178,0.001969431],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.604277,"threshold_uncertainty_score":0.9999219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2586519388","doi":"10.1001/jamaoncol.2016.6728","title":"Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; GiST; Imatinib mesylate; Internal medicine; Imatinib; Oncology; Clinical trial; Clinical endpoint; PDGFRA; Randomized controlled trial; Survival rate; Gastroenterology; Stromal cell","retraction":null,"screen_n_in":null,"score":{"opus":0.08707842160318213,"gpt":0.3551595821378414,"spread":0.2680811605346593,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005452349,0.0001565072,0.0004661375,0.0001754127,0.00007882694,0.00001983564,0.0001381762,0.00004904779,0.00001085337],"category_scores_gemma":[0.002645466,0.0001240319,0.0000552947,0.0000939524,0.000260291,0.0002431685,0.0000597515,0.0003078929,0.00000482123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004072743,"about_ca_system_score_gemma":0.0006650946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000676003,"about_ca_topic_score_gemma":0.001573599,"domain_scores_codex":[0.9982295,0.0001156492,0.000694498,0.0003155184,0.0003180027,0.0003268326],"domain_scores_gemma":[0.9979327,0.0002304621,0.0008659635,0.0004702926,0.0003621883,0.0001383819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02813953,0.0007566554,0.7561277,0.0001838463,0.00003687194,0.004180857,0.0003605748,0.001354497,0.1759513,0.00009418712,0.00007058214,0.03274338],"study_design_scores_gemma":[0.01804199,0.01737135,0.9365907,0.001486748,0.00003900506,0.002876059,0.0002082211,0.008089599,0.01519582,0.00001680594,0.000003338511,0.00008034262],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939097,0.00001581608,0.0005828777,0.0009746283,0.00003491082,0.0005689126,0.00004746706,0.00001451484,0.003851161],"genre_scores_gemma":[0.9749793,0.000004887431,0.02454702,0.00001355443,0.00008019709,0.00002495817,0.0001929111,0.00001418185,0.0001429541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.180463,"threshold_uncertainty_score":0.5057875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2546973056","doi":"10.1001/jamaoncol.2016.4884","title":"Association of Polymorphisms in <i>FCGR2A</i> and <i>FCGR3A</i> With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Breast cancer; Regimen; Cyclophosphamide; Cohort; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.02793474528304624,"gpt":0.3318939157411339,"spread":0.3039591704580877,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005692937,0.0001494297,0.0007055716,0.0001854232,0.00001528827,0.000002735006,0.0001162989,0.0001997057,0.00009169342],"category_scores_gemma":[0.00006718426,0.00007924082,0.00005706253,0.0003580609,0.0002414685,0.0000647241,0.00002720445,0.0001468058,0.000001267809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001727168,"about_ca_system_score_gemma":0.0006964933,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0100883,"about_ca_topic_score_gemma":0.0240331,"domain_scores_codex":[0.9982821,0.0002452247,0.0004732085,0.0002482913,0.0004278998,0.0003232718],"domain_scores_gemma":[0.9982941,0.0008371047,0.0003322582,0.0002395782,0.0002326993,0.00006432464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00249806,0.001077069,0.6150602,0.00006250395,0.0001464769,0.0000697398,0.003012909,0.000003652409,0.02377381,0.0001029704,0.0003824835,0.3538102],"study_design_scores_gemma":[0.009944567,0.005811273,0.9570828,0.0005807162,0.0001170373,0.00009843647,0.0004956083,0.0000120279,0.02456203,0.00007899087,0.001131695,0.0000848032],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711885,0.001063198,0.000006519931,0.02431382,0.00004453512,0.0007416399,0.0003271616,0.000004463519,0.002310183],"genre_scores_gemma":[0.9976174,0.001448384,0.0001161979,0.0002538922,0.00006672521,0.0001594706,0.00000618041,0.00001762637,0.0003140823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3537253,"threshold_uncertainty_score":0.9965036,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}